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Overview 
 
The role of pharmacists in the healthcare sector is vital. In Indonesia, 
medicines accounted for 12 – 38% of hospitals’ expenses, and hospital 
pharmacy is the main department in the hospital charged with the 
responsibility to manage the safe, appropriate and judicious use of 
medicines. Many studies have investigated clinical and financial benefits of 
pharmacists and pharmaceutical services in hospitals. To assist authorised 
bodies in each country to establish relevant document and regulations, World 
Health Organization (WHO) and International Pharmaceutical Federation 
(FIP) have stipulated Good Pharmacy Practice (GPP) guidelines. Hospital 
pharmacy practice standards have also been ratified in many countries, and 
a global consensus was developed and called “The Basel Statements on the 
future of hospital pharmacists”. It reflects the importance of service provision 
by hospital pharmacy.  
 
However, much variation of hospital type, ownership (private or public), and 
stage of regional development is common in Indonesia. With constant 
changes in healthcare industry, such as change of health systems, patients’ 
demography, or advancement of medical technology and science, many 
hospital pharmacies face challenges to meet the practice standards. For 
example, with the implementation of National Health Insurance scheme in 
Indonesia in early 2014, the medicines funding scheme was changed. 
Healthcare funding which was previously dominated by private health funds 
 x  
has been reformed into public funding using case mix. In the old scheme, 
medicines costs were paid out-of-pocket by patients, or fully reimbursed by 
private or public health insurance bodies. In the new scheme, medication 
costs are paid as a package with other health costs. Hence, hospital 
pharmacy plays a vital role in managing medicines to improve efficiency and 
service quality as well as managing financial sustainability. 
 
Management is an essential factor to ‘scale up’ service delivery to 
strengthening health systems and improving population health in low-middle 
income countries. Managers in the hospital sector are key health service 
managers especially in low income countries. Although the importance of 
management in hospital pharmacy is clear, it is common for many hospital 
pharmacists to overlook rather than value management practice. While there 
has been some research reported from developed countries, there is 
relatively little current research from developing countries. Research 
exploring hospital pharmacists’ experiences in hospital pharmacy 
management is critical to gain more understanding about current issues, and 
potential future application of management in hospital pharmacy. Therefore, 
the aims of the research described in this thesis were to explore Australian 
and Indonesian hospital pharmacists’ perceptions of their roles in hospital 
pharmacy management, challenges and enablers in managing hospital 
pharmacy, and vision for the future.  
 
 xi  
This research has adopted a qualitative approach using semi-structured 
interviews in two stages. Stage 1 explores the Australian hospital 
pharmacists’ and Stage 2 investigates Indonesian hospital pharmacists’ 
perceptions and experiences in hospital pharmacy management. The main 
focus of this research is on Stage 2, thus the results are presented in three 
chapters. However, Stage 1 provides an international perspective and 
commentary for the findings in Stage 2. 
 
In Chapter 1, an overview of the literature regarding hospital pharmacy 
management, details of the Australia’s and Indonesia health systems, and 
hospital pharmacy activities in each country are summarised and discussed. 
It also includes a structured literature review to explore international 
perspectives on management aspects in hospital pharmacy. The results are 
presented and discussed in this chapter. 
 
In Chapter 2, the Stage 1 of this research is presented comprising a 
qualitative study exploring the perceived roles, challenges, opportunities, and 
key factors in managing and optimising resources in Australian hospital 
pharmacy. The main themes identified from semi-structured interviews are 
summarised and discussed in this chapter. 
 
In Chapter 3, the first part of Stage 2 of this research is documented. A 
qualitative study was conducted to explore perceived roles, challenges, 
 xii  
opportunities, and key factors in managing and optimising resources in 
Indonesian hospital pharmacy. This chapter focuses on Indonesian hospital 
pharmacists’ perceptions of roles, barriers and facilitators of roles, and 
attitudes toward current roles. The main themes identified from semi-
structured interviews are summarised and discussed in this chapter.  
 
In Chapter 4, the second part of Stage 2 is documented. This chapter 
focuses on Indonesian hospital pharmacists’ experiences and concerns in 
the management of hospital pharmacy. The main themes identified from 
semi-structured interviews are summarised and discussed in this chapter. 
 
In Chapter 5, the last part of Stage 2 is documented. This chapter focuses 
on the views and perceptions of Indonesian hospital pharmacists related to 
the professions’ future direction and vision for hospital pharmacy practice. 
The main themes identified from semi- structured interviews are summarised 
and discussed in this chapter. 
 
In Chapter 6, main findings of each project stage from each stage are 
compared and summarised. Future directions in this area are discussed in 
this chapter. 
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1. Hospital Pharmacy Management: an Overview of the literature 
 
 
 Hospital pharmacy 
Many countries have standards for hospital pharmacy practice to guide 
hospitals and hospital pharmacists. For example, in the United States (US), 
the American Society of Health-System Pharmacists (ASHP) stipulates 
professional standards, such as minimum qualifications for Directors of 
Pharmacy, guidelines for medicines information, policy development, 
distribution roles, operation management, and research pharmacists’ roles 
(1). In Australia, hospital pharmacists perform clinical and distribution 
services, education, research, administration, and quality management (2). In 
Indonesia, hospital pharmacists manage inventory and its associated risks, 
provide clinical services, manage human resources, facility and equipment, 
develop and implement institutional drug policies, and manage quality (3). 
Although minimum standards have been ratified, the scope of services may 
vary from one hospital to another depending on the needs of the patients 
served by that institution (4). 
 
The Pharmacy Department is an integral part of hospital-based health care 
and should be regarded as such. For example, if the pharmacy department is 
managed under ancillary services within the hospital’s organisational 
structure along with housekeeping, the pharmacy department is more likely 
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to be viewed as a service department (4). Alternatively, if the pharmacy 
department is under the clinical support or patient care division within the 
organisation, then pharmacy and the hospital’s pharmacists will be viewed as 
participants in direct patient care (4). In some hospitals, the pharmacy 
department is managed as a business or commercial division within the 
organisational structure along with other commercia services such as the 
florist or coffee shop. In these situations, pharmacy is an external service 
brought into the hospital to provide medicines and may not be directly 
involved in patient care. Different organisational structures can have a major 
impact on the ultimate role of hospital pharmacy. 
 
1.1.1. Practice models 
Across the globe, hospital pharmacy has implemented one of three broad 
types of practice models to varying degrees among different nations or within 
each country (5, 6). Firstly, the drug-distribution-centred model was the most 
commonly implemented in many hospitals (5-7). The drug-distribution-
centred model is focused on distribution of medicines with limited clinical 
service provision. Secondly, the less common clinical-generalist model (5, 7) 
occurs when pharmacists manage all aspects of medication use, both clinical 
and distributive functions (5, 7). A less common clinical-specialist-centred 
model (6, 7) is one which separates pharmacists’ functions between clinical 
and distributive roles. Although current practice models in some countries still 
focus more on distributive roles, much activity has shifted toward clinical 
roles (6). 
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1.1.2. Resources 
There are three essential resources in hospital pharmacy. Human capital is 
critical in hospital pharmacy (5, 6, 8), as shown across the globe. In many 
countries, the pharmacy workforce is predominately female (5). Workforce 
shortages are common (5), and working in hospital pharmacy is not a career 
preference for many pharmacists in some areas (6). Access to medicines 
information is also critical for service provision (5, 9), but the degree of 
access to relevant information may vary (5). Although most high Human 
Development Index (HDI)1 countries have at least one computer and access 
to the internet in every pharmacy department, many countries with low and 
medium HDI still have limited access to computers or internet for accessing 
information (5). Moreover, funding and the capacity to control the allocation 
of funds are of ‘utmost importance in maintaining an institution’s solvency’ 
and financial stability (4). For example, ten nations in the WHO African region 
consumed greater than one third of their nations’ healthcare resources for 
disease treatments (5), and the growth of pharmaceutical expenditure was 
similar to the growth of healthcare expenditures in the US (10). Managing 
limited resources remains a constant challenge for hospital pharmacy. 
 
 
                                                            1 Human Development Index is a summary measure of average achievement in key dimensions of human development: a long and healthy life, being knowledgeable and having a decent standard of living. 
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 Pharmacy management 
Pharmacy practice has evolved from preparation and distribution of 
medicines to more patient-oriented, clinical pharmacy practice. Expansion of 
pharmacists’ roles was facilitated by better understanding of drug-related 
morbidity and mortality which could be prevented by pharmaceutical services 
(11). In the 1990s, contrasting opinions about what 'patient-oriented care' 
meant has impeded clarity about professional identification and role definition 
(11). A number of definitions of pharmaceutical care have been practiced 
across the globe (6). The philosophy, which emphasized clinical practice and 
quality of care, may have influenced many pharmacists to prioritise clinical 
rather than their managerial roles (12). However it might be considered that 
all hospital pharmacists are managers (4). 
 
 1.2.1. Definition of management 
Management may refer to the act of 'managing', or a collective body which 
manages others. In Merriam-Webster dictionary, to manage is defined “to 
have control of, take care of, make decisions about, and direct something or 
someone” (13). Management is also defined as “a process which brings 
together resources and unites them in such a way that, collectively, they 
achieve goals or objectives in the most efficient manner possible” (14). The 
WHO outlined that effective management is one essential component 
required to 'scale up' the quantity and quality of health services and to 
improve population health (15).  
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In Fayol’s classic management theory, there are four management activities 
(16). The first is planning, which is the 'purposeful efforts taken by an 
organisation to maximise its future success' (17). The next activity is 
organising or the 'arrangement and relationship of activities and resources 
necessary for the effective accomplishment of an objective' (16). The next 
step is leading, which involves 'bringing about purposeful action toward some 
desired objectives' (16). The final activity is 'controlling or review of the 
progress which has been made toward the objectives that have been set up 
in a plan' (16). Management activities should be performed in order, and are 
meant to be run as a cycle (Figure 1.1) (16). 
 
Figure 1.1. The cycle of management activities  
  
 
 
 
1.2.2. Pharmacy management in the Australian context 
 Australian health system 
To understand how hospital pharmacy works in Australia, the national health 
system must be understood. As at 2016, the population of Australia was 
Plan
Organise
Lead
Control
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estimated at 23.99 million (18). Australia’s healthcare system is a multi-
faceted web of public and private providers, settings, participants and 
supporting mechanisms (19). The system is multi-tiered. For most people, 
the first point of contact to health services is through primary care, and they 
may then be referred to a specialist or a public hospital for other treatment 
options (19). In Australia, the state governments oversee the public hospital 
system (tertiary health healthcare); whereas the Commonwealth government 
is predominantly responsible for primary care. (19). 
 
Private hospitals are mainly owned and managed by private organisations, 
either for-profit or not-for-profit non-government organisations (20). Private 
hospitals are mainly funded by private health insurance and out-of-pocket 
payments by patients (20). In 2013-14, there were 89,500 beds (2.5 
beds/1,000 people), and 1,359 hospitals (59% are public) which are very 
diverse in size and types (20). In 2011-12, health expenditure in Australia 
was AU$140.2 billion (19), which was 9.4% of GDP or US$6,110 per capita 
(21, 22), and 40.4% was for hospital expenditure (19). 
 
 Management activities 
Management of pharmacy services in Australian hospitals includes several 
defined activities. According to the SHPA Definitions of Hospital Pharmacy 
Services, hospital directors of pharmacy departments are responsible for 
pharmacy resources, such as human capital, money, pharmaceutical 
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materials, educational materials, assets, and revenue (2). Hospital pharmacy 
managers participate in strategic planning and hospital pharmacy policy 
development (2). In addition, the hospital pharmacy manages information, 
either computerised or paper-based (2). Hospital pharmacy manages risk 
and occupational health (2), and is also responsible for secretarial and 
administrative activities (2). 
 
1.2.3. Pharmacy management in the Indonesian context 
 Indonesian health system 
In 2014, Indonesia had a total population of 254.5 million (23). However, the 
population density ranged from <9 people/km2 (in West Papua) to >15,063 
people/km2 (in Jakarta) (24). Around 80% of Indonesians live in Java and 
Sumatera Islands (25). Indonesia implemented a universal health insurance 
system, known as JKN, in 2014. This new health system was expected to 
reform health financing system in Indonesia, which had been dominated by 
privately funded health services. (26).  
 
Healthcare services in Indonesia are divided into either primary healthcare 
centres or hospitals. All primary healthcare centres are funded and operated 
by the Indonesian and provincial governments (24). Public hospitals are 
funded and run by either the Indonesian or provincial governments, and may 
not be converted into private hospitals (27). Private hospitals are operated by 
for-profit non-governmental organisations (27). In 2013, there were 2,228 
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hospitals (70% public hospitals), and beds per head of population ranged 
from 0.65/1,000 people in West Nusa Tenggara to 2.95/1,000 in Jogjakarta 
(24). Health expenditure in Indonesia was 3.1% of GDP (US$107 per capita) 
(21, 22). 
 
 Management activities 
Pharmacy management in Indonesian hospitals involves inventory and risk 
management. The pharmacy department is the sole manager of 
pharmaceuticals, medical devices, and consumables (3, 27). Inventory 
management includes drug selection, formulary development, drug-use 
forecast, drug procurement, production, storage, distribution, and control of 
pharmaceuticals, medical devices, and consumables (3). To manage 
inventory, administrative tasks include providing drug use and financial 
reports (3). Risk management includes identification, assessment, and 
follow-up on patient safety and occupational health (3). 
 
1.2.4. Review of current literature 
 Literature search 
To understand international perspectives on management aspects in hospital 
pharmacy, a review of literature was conducted. To be included in this 
review, references had to be relevant to hospital pharmacy, and include 
aspects of financial management, personnel management, leadership, 
information management, planning, and/or risk management.  
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Studies were identified by searching the following electronic databases: 
Medline via Ovid and International Pharmaceutical Abstracts. Search terms 
included “hospital pharmacy”, “financial management”, “personnel 
management”, “risk management”, “materials management”, “information 
management”, “time management”, and “organisation and administration” 
alone and in combination with each other. Hand searches of bibliographies of 
relevant articles and authors’ personal files were also performed. 
 
Studies concerning clinical trials, customer relations, drug administration and 
utilization, health outcomes, medication and disease management, 
medication error and patient safety, medication risk, patient and pharmacists 
education, prescribing and dispensing were excluded. Studies which were 
not written in English and meetings abstracts were also excluded. 
 
 Results of literature search 
The literature search yielded 513 articles published between 1963 and 2013. 
Based on the abstracts, articles were excluded from the review because they 
focused on customer relations, drug utilization, medication and disease 
management, medication error and patient safety, medication risk, non-
hospital based, patient education, pharmacists education, prescribing and 
dispensing, meeting abstracts, non-English literature, health care outcomes 
or costs without changes, that changes occurred in short period of time, and 
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not accessible. The focus of the search was to identify primary research 
papers. However, only a limited number of primary research papers (n=4) 
were found. Therefore, further exploration to include grey literature revealed 
case reports, case studies, commentaries, conference proceedings, practical 
advice, and symposium material. There were other hand-searched articles 
included. The 35 articles reviewed were categorised according to the area in 
hospital pharmacy management: financial management, strategic 
management, inventory management, organisational structure and 
behaviour, personnel management, and risk management (Table 1.1). 
 
Table 1.1. Articles included for review based on category, type of citations, author(s), published year, country of origin, and type of hospital settings  
 
Category Type Author Year Country Type of hospital settings Financial management Primary research article 
Sloan, FA, K Whetten-Goldstein, and A Wilson 
1997 US Public hospitals For profit hospitals Voluntary hospitals 
Primary research article 
Krugman, M, et al 2002 US Tertiary teaching hospital 
Case report Kernich, CA and FA Creighton 
2004 US Tertiary academic hospital 
Strategic management Commentary Grainger, H 1963 UK N/A Commentary Buccerl, P and JA Baker 1978 N/A N/A Case report Kay, BG and DN Adelman 1979 US Teaching hospital Proceeding Skolaut, MW 1980 US N/A 
Commentary Wilson, CN 1994 US N/A 
Case report Janning, SW JG Stevenson, and RT Smolarek 
1996 US Tertiary academic hospital 
Case report Hintzen, BL, et al 2009 US Teaching hospital Case study Crumb, DJ 2010 US Community hospital 
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Category Type Author Year Country Type of hospital settings Case study Knoer, SJ, JD Pastor, 3rd, and PK Phelps  
2010 US Teaching hospital 
Inventory management  
Symposium Raber, JH 2010 US N/A 
Organisational structure and behaviour 
Commentary Gayatonde, NS 1969 India N/A Commentary Gibson, J 1991 South Africa Public hospitals Primary research article 
Raehl, CL, CA Bond, and ME Pitterle 
1992 US Acute-care general medical or surgical hospitals (> 50 beds) 
Commentary Scheider, PJ 1999 US N/A 
Primary research article 
Raynor, DK, et al 2000 UK N/D 
Symposium Wollenburg, K 2001 US Independent pharmacy, hospital pharmacy, chain pharmacy Primary research article 
Firzpatrick, RW and HF Boardman 
2005 UK N/D 
Commentary Gallego, G, SJ Taylor, and JE Brien 
2006 Australia Public hospitals Private hospitals 
Primary research article 
Bond CA and Raehl CL 2007 US Acute-care general, medical or surgical, paediatric hospitals (> 50 beds) Case report Vora, S and T Cohen 2007 US Combination of academic and community hospitals Primary research article 
Bond, CA and CL Raehl 2008 US Acute-care general, medical or surgical, pediatric hospitals (> 50 beds) 
Personnel management Commentary Fine, DJ 1985 US N/D Primary research article 
Bond, CA, CL raehl, and T Franke 
1999 US General, medical or surgical hospitals 
Practical advice Davis, D. 2002 US Community hospital Primary research article 
Bond, CA, CL raehl, and T Franke 
2002 US General, medical or surgical hospitals 
Primary research article 
Bond, CA, CL Raehl, and R Patry 
2004 US N/D 
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Category Type Author Year Country Type of hospital settings Primary research article 
Kahaleh, A and C. Gaither 2007 US Teaching hospital and community hospital (public or private) Primary research article 
Babigumira, JB, et al 2009 Uganda Public hospitals 
Case report Krogh, P, J Ernster, and S Knoer 
2012 US Teaching hospitals 
Risk Management Case study Pick, AM, et al 2006 US Acute-care, non-profit hospital 
Symposium Shane, R 2009 US Teaching hospital 
Primary research article 
Garrett, T, B Stokes, J Brien 
2013 Australia Public hospitals 
N/A: Not applicable; N/D: Not defined  
 Financial management 
All the studies that were related to financial management originated in the 
US, since 1980s. This seems consistent with the described 'evolution' of US 
health care system which consisted of three stages. The first stage has been 
described as a “quality crisis” which occurred before World War II, the 
second stage was “access crisis” which emerged from 1960 to 1970, and the 
third stage was “cost crisis” which commenced from 1970 (28).  
 
Cost-effectiveness and cost-containment were identified as major issues for 
hospitals. Sloan, et al stated that the importance of cost-effectiveness was 
initiated by limited budget, and integration of health-financing system which 
shortened lengths of stay and affected drug selection process (29). In a 
quasi-experimental study conducted at a teaching hospital, Krugman, et al 
reported that educational materials to promote employees’ financial 
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awareness were beneficial to deliver cost-effective services (30). However, 
the authors also highlighted that among healthcare professionals who 
participated in the experiment, pharmacy staff showed the most significant 
improvement in financial knowledge (30). Furthermore, Kernich and 
Creighton reported a case study on management of specialty 
pharmaceuticals at a teaching hospital in the US (31). In the report, the 
authors demonstrated that standardised protocols, cooperation among all 
staff, and audits could be utilised to optimise the financial management of 
specialty pharmaceuticals (31). 
 
 Strategic management 
Managing strategy was the primary focus of eight articles, with seven of the 
publications from the US and one from the United Kingdom (UK). Historically, 
hospital pharmacy planning activities resulted from changes in education, 
national health systems, and/or consumer demands. For example, before the 
provision of National Health Service (NHS) in the UK, pharmacists worked in 
dispensary and could be substituted by other professions (32). After the 
NHS, hospitals were granted much autonomy, and hospital pharmacists 
expanded their roles to drug formulation, influencing prescribers, and 
supervising pharmaceutical services (32). In 1979, Kay and Adelman 
reported a case study of a change management from a teaching hospital in 
the US (33). The authors outlined processes in changing the traditional 
dispensing system to ‘a more efficient, patient-oriented, unit dose system,’ 
and resulted in more supportive environment for clinical pharmacy service 
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provision (33). Additionally, Skolaut forecast fundamental changes in hospital 
pharmacists’ roles in the US towards clinical specialists to meet increasing 
consumer demands for excellence and affordability over 1980s (34). In 2010, 
Knoer et al reported a shift from baccalaureate-trained pharmacists to Doctor 
of Pharmacy (Pharm.D) in an affiliated university facilitated pharmacy 
practice model change at a hospital in the US (35). Those reports provide 
some insights of significant impacts of external environment to hospitals on 
pharmacy department. 
 
Some techniques to assist hospital pharmacists in strategic management 
were also reported. In 1994, Wilson outlined ten key trends in healthcare 
industry to equip hospital pharmacists in development of survival strategy 
(Table 1.2) (36). Another tool used in one US hospital was lean process 
improvement technique (37). The main objective of lean technique was to 
improve efficiency and quality of pharmaceutical production and distribution 
processes by improvements of work flow and ‘visual control’ (37). 
Table 1.2. Ten key financial trends influencing hospital industry 
Key trends: 
1. Decrease in hospital size and occupancy rates 
2. Decrease in average length of stay 
3. Increase in complexity of case mix 
4. Increase in outpatient visits 
5. Decrease in capital-related expenses 
6. Decrease in financial leverage 
7. Increase in debt service coverage 
8. Decrease in net accounts receivable 
9. Increase in staffing level 
10. Increase in hospital profitability 
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However, some attitudes towards change management process were also 
reported previously. Bucceri and Baker proposed potential challenge in 
change implementation, which includes staff resistance and complaints (38). 
Knoer et al described how pharmacy members expressed their fear and 
confusion at role changes at a teaching hospital in the US (35). Nevertheless, 
the authors also reported such resistance and fear were manageable through 
mediation, engagement, and mentoring (35).  
Some challenges in managing strategy in pharmacy departments have been 
reported. Government and pharmacists’ associations were also recognised to 
enable the development of the professions, through research and 
development of guidelines and standards (32). However, disparity in 
institutional capacity to meet the national standards decreased the 
effectiveness of such standards (39, 40). For example, in 1960s, inability to 
hire pharmacists and inadequate education hampered potential development 
of hospital pharmacists’ roles outside dispensing and supplying medicine 
(32). In addition, personal characteristics – to be specific: interests, career 
aspiration, beliefs, passion, preferences, and commitment, were potential 
barriers or facilitators of change (35, 41). 
 
 Inventory management 
There was only one citation which emphasized the importance of inventory 
management to improve medication safety. In 2007, the Food and Drug 
Administration (FDA) established Risk Evaluation and Mitigation Strategies 
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(REMS) which required complex administration and procedures for 
potentially problematic drugs (42). For example, Raber reported that 
droperidol (a drug with black box warning) required a pregnancy test, 
electrocardiograph, and opiate tolerance test prior to prescription (42). The 
author suggested medication risks to be integrated during formulary 
development by specific protocol and involvement of clinical pharmacy in 
formulary process (42). 
 
 Organisational structure and behaviour 
Articles focused on organisational structure and behaviour were published 
from 1969 to 2008. Unlike other aspects of management highlighted in this 
literature review, these papers were published from four countries, and over 
a long time period. This may indicate that organisation of hospital pharmacy 
has been a more broadly canvassed area of study.  
 
Some countries reported their hospital pharmacy practice model. In an earlier 
period (the 1960s), Gayatonde reported that the model of hospital pharmacy 
services in India was focused on drug supply and manufacture, and offered 
poor incentive to qualified persons (43). In 1989, Raehl, et al reported some 
US hospital characteristics which determined the extent of clinical pharmacy 
services (Table 1.3) (44). In 1991, in South African context, Gibson proposed 
organisational development to attain ‘a proclaimed, ideal future’ of hospital 
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pharmacists (45). The author also described that pyramidal organisations 
hindered pharmacists’ participation, and job satisfaction (45). 
 
Table 1.3. Five factors related to clinical pharmacy service provision in US hospitals  
Factor Influence on service provision 
Hospital size Larger hospitals offered more clinical services 
Affiliation with a university Teaching hospitals offered more clinical services 
Hospital ownership Federal government hospitals offered more clinical services; the difference between non-profit or for-profit hospitals varied 
Pharmacy drug delivery system Decentralised pharmacy offered more clinical services 
Director of Pharmacy’s education Pharmacy with directors with advanced pharmacy degree offered more clinical services 
 
Some articles highlighted professional autonomy and positive impacts of 
hospital pharmacists. In a commentary published in 1999, Schneider 
highlighted potential clinical leadership opportunities for hospital pharmacists 
to improve medication safety, access to healthcare, and treatment outcomes 
(46). Bond et al conducted a national survey to investigate potential 
relationships between clinical pharmacy services, pharmacy staffing, and 
mortality rates (47). The result showed that an increase in the number of 
clinical pharmacists significantly increased outcomes for all variables, but an 
increase in pharmacy administrators increased mortality rates; however the 
number might not show how administrators directly affect the quality of care, 
but could represent how hospital pharmacies were organised (47).  
Some authors also emphasized the implications of main organisations’ 
structures on hospital pharmacies. Two studies in the UK reported that local 
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organisation and pharmacy directors’ perceptions led to various extent of 
service provision (39, 40). Two studies pointed out the challenges in 
managing hospital pharmacy in different types of institutions under one 
authority. An incorporation of larger and smaller hospitals which shared the 
same resources and leadership were characterised by instability, conflicts, 
and lack of vision (48). A large network hospital also had different scope of 
services and priorities which were determined by the structure and 
philosophy of the organisation (41). In 2006, Gallego et al commented on 
potential impact of fragmented hospital funding system in Australia (49). In 
the system, public and private hospitals had different source of funds to 
supply medications, where private hospitals had quite flexible funds (49). The 
authors were also concerned about equity of access to medications, 
efficiency, and potential treatment outcomes in public hospitals (as opposed 
to private hospitals) (49). 
 
 Personnel management 
The focus of two articles related to personnel management was how to 
develop the organisational structure to increase empowerment and loyalty of 
staff. Fine described that recent roles of the hospital pharmacist were of the 
'drug resource manager, drug system manager, drug information manager, 
and drug therapy manager' (50). Fine also criticised the pyramidal structure 
of US hospitals which created a competition between pharmacy and other 
departments (50). In contrast, the author argued that matrix organisation 
would secure flexibility, horizontal communications, and emphasized 
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knowledge instead of power (50). Moreover, in 2007, Kahaleh and Gaither 
found that pharmacists who worked in independent pharmacies had higher 
level of perceived empowerment and greater loyalty compared to 
pharmacists working under a structured organisation (51). Increase of access 
to knowledge, opportunity, and support were recognised to influence 
pharmacists’ loyalty and commitment to work (51). 
 
Two studies presented how shortages of health care professionals were 
managed. Davis reported that in 1993, a community hospital in the US was 
short of pharmacists and nurses (52). By use of a computerised system and 
hiring pharmacy technicians, pharmacists were assisted in preparation of 
medications, so nurses and pharmacists could focus more on direct patient 
care (52). However, pharmacy technicians had limited clinical expertise, so 
the hospital hired ‘licensed practical nurses’ who could assist both nursing 
and pharmacy departments (52). After the implementation of these changes, 
time devoted to patient care increased, phone call frequency decreased, and 
medication issues were solved promptly (52). Furthermore, in Uganda, 
Babigumira et al carried out a cost-minimisation model to assess potential 
task shifting in antiretroviral therapy monitoring from physicians to nurses and 
pharmacists to increase access to health care (53). The result showed that 
shifting therapy monitoring to nurses and pharmacy workers could save $11 
million/year and 14.8% of physician full-time equivalent (FTE) in Uganda 
(53). 
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A set of national surveys in the US conducted by Bond et al identified a 
relationship between hospital pharmacy staffing, clinical pharmacy services, 
cost of care, and mortality rates. In 1999, the authors reported that with an 
increase in the number of clinical pharmacists, drug costs decreased 
because of the associated clinical pharmacy services (54). In 2002, Bond et 
al surveyed clinical pharmacist staffing and factors related to staffing levels, 
where pharmacy leaders had a role in resource allocation (55). In 2004, Bond 
et al investigated the feasibility of and factors affecting the implementation of 
clinical pharmacy core set of services (56). The core set included ‘drug 
information, adverse drug reaction management, drug protocol management, 
medical rounds, and admission drug histories’ (57). It was projected that 
pharmacists’ competencies and availability would satisfy these demands. 
The pharmacy leadership in the US strongly supported the implementation of 
these services (56). 
 
Although cost of care and quality of care may justify the services and staffing 
requirements, a recent study conducted by Krogh et al introduced the use of 
a productivity measurement tool to justify workload and working hours (58). 
The authors reported the use of an electronic census system increased 
accuracy of workload assessment, hence facilitated improved ‘staffing-to-
demand model’ and contained labour costs (58). 
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 Risk management 
Two articles focused on medication safety as a risk management issue for 
hospital pharmacists. There were different approaches to manage risk. Pick 
et al managed safe use of medication by developing tools to examine a 
safety level for formulary candidate medications. In this study, potential risks 
of medicine could be identified in the formulary selection before they were 
used (59). Shane suggested collaboration of healthcare professionals, 
including pharmacists, to balance the FDA’s drug safety requirements and 
patients’ safety (60).  
 
On the other hand, Garrett, et al emphasized the importance of a safety 
culture to manage medication safety (61). The authors reported safety culture 
was influenced by many factors, such as hospital type, professional group 
within pharmacy, and professional organisation affiliation. A survey 
conducted in public hospitals showed that staff in smaller hospitals reported 
very positive responses to team work, staffing levels, and management (61). 
Pharmacists that were affiliated with professional organisations showed very 
positive and supportive attitudes toward medication safety (61). However, 
pharmacy technicians demonstrated the lowest level of support for safety 
culture, particularly in new roles that were created to support clinical 
pharmacy activities (61). 
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1.2.5. Conclusion 
From the review of the literature, it is apparent that management of hospital 
pharmacy has been a global interest of study. However, some aspects of 
hospital pharmacy management, such as strategic management, 
organisational culture and behaviour, and personnel management, seemed 
to receive more attention than the others. A limitation of this review is we only 
utilised two databases, many articles were grey literature, and many were 
more than five-years old. It is also apparent that the majority of publications 
were conducted in the context of developed countries, and little has been 
reported about developing countries. Hence, since the constantly changing 
healthcare industry may pose potential challenges particularly in low 
resource settings, exploration of management of hospital pharmacy in 
developed and developing countries may yield beneficial insights on current 
and future hospital pharmacy practice.  
 
In the following chapters, exploration of hospital pharmacy management from 
the Australian and Indonesian perspectives are described. 
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3. Management of Hospital Pharmacy in Australia 
 
 
Background: Management is a challenging yet essential area in 
strengthening a health system and improving population health. 
Nevertheless, it has appeared common for pharmacists to overlook or shun 
management practice, because business was perceived ‘ethically 
inconsistent’ and had nothing to do with pharmacists’ roles in community 
health and patient care. 
Objective: The aims of this chapter were to Australian hospital pharmacists’ 
perceptions of their responsibilities, challenges and key factors in managing 
pharmacy, as well as to explore potential future development. 
Methods: A qualitative study using semi-structured interviews and grounded-
theory approach was conducted to describe the experience and perceptions 
of participants. 
Results: Nine hospital pharmacists from New South Wales (NSW) hospitals 
in Australia were interviewed. Ideas about how hospital pharmacy should be 
managed are still debated. A number of issues of importance were raised by 
participants. Skills, leadership, and environment were endorsed as key 
factors. Professional career development and appreciation were required. 
Funds and pharmacists’ attitudes were reported as potential challenges in 
the future. 
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Conclusion: Many aspects of management skills are required. With constant 
tensions between professional autonomy and multidisciplinary environments, 
pharmacists may lack motivation. Leadership in pharmacy must be realised 
to foster accountable practice. Support from hospital executives, regulators, 
professional organisations, pharmacy educators, and other practitioners 
should be sought.  
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 Introduction 
Management is a challenging yet essential area in strengthening a health 
system and improving population health (1). Management is defined as “a 
process which brings together resources and unites them in such a way that, 
collectively, they achieve goals or objectives in the most efficient manner 
possible” (2). There may be different areas of management experience and 
skills that are relevant for hospital pharmacy managers. Financial 
management has been identified as being important for hospital pharmacy 
managers because of responsibilities in overseeing a hospital’s medicines 
formulary. The formulary typically involves a drug selection process based on 
cost-effectiveness and risk management (3). Personnel management is also 
a vital factor in the success of hospital pharmacy service delivery (4). 
Nevertheless, it has appeared common for pharmacists to overlook or shun 
management practice, because business was perceived ‘ethically 
inconsistent’ and was perceived to have little to do with pharmacists’ roles in 
community health and patient care (5). 
 
There may be different perspectives on the role of management for hospital 
pharmacists. Several ways to integrate management techniques into hospital 
pharmacy practice have been adopted (6-10). The use of a cost-
effectiveness approach in managed-care services has been explored by 
Sloan et al (8). Using this approach, the authors outlined the utilisation of 
cost-effectiveness analysis to develop hospital formulary, but ‘lack of 
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information on hospitalised patients and costs, lack of independent 
sponsorship, and inadequate expertise’ were found to hinder its utilisation 
(8). Wilson proposed some key financial trends shaping hospital industry, 
such as ‘average length of stay, complexity of case mix, and outpatient use’ 
to equip hospital pharmacy managers to develop strategies in the constantly 
changing hospital environment (9). Moreover, the way an organisation is 
structured is also considered a critical aspect in the provision of hospital 
pharmaceutical services (6, 7). Furthermore, medication safety has been 
identified as an important management priority, especially in hospital 
pharmacy. Hence, management of risk is a key component of medication 
safety and an important role led by pharmacists in the hospital setting (10).  
 
The major focus of this thesis is the development of hospital pharmacy 
management in Indonesian hospitals with an international perspective. In this 
chapter, perceived roles, challenges, opportunities, and key factors in 
managing and optimizing resources in Australian hospital pharmacy are 
described. Views on potential future development of hospital pharmacy are 
also explored. Qualitative research involving key informants in Australian 
hospital pharmacy was conducted for this purpose. 
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 Objectives 
This study aimed to explore Australian hospital pharmacists’ perceptions of 
their responsibilities, challenges and key factors in managing pharmacy, as 
well as to explore potential future development. 
 
 Methods 
A qualitative study using an inductive approach was conducted to describe 
the experience and perceptions of participants in management of hospital 
pharmacy services. Given the aim of the study was to obtain description and 
interpretation of a phenomenon, qualitative approach was deemed 
appropriate. Face-to-face, semi-structured interviews were conducted 
between December 2014 and May 2015. Prior to commencement, the 
research was assessed and approved by the Human Research Ethics 
Committee of the University of Sydney (Project number 2014/680).  
 
Initial key informants were recruited using a purposive and convenience 
sampling approach, using an invitation letter (Appendix 2.1) and consent 
form (Appendix 2.2). Given the aim and nature of this study was not to 
achieve a representative population, the purposive recruitment approach was 
deemed appropriate. An interview protocol (Appendix 2.3) was developed 
informed by the literature on hospital pharmacy management and three pilot 
interviews were undertaken to establish the face validity of the questions.  
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The interview guide is shown in Table 2.1 Interviews were audio-taped and 
field notes were taken. Audio-recordings were transcribed verbatim. Data 
were entered into NVivo qualitative data analysis Software; QSR 
International Pty Ltd. Version 11, 2015. During data collection period, each 
transcript was analysed for emerging themes, and coded using descriptive 
and focused coding (11). 
 
Table 2.1. Topics covered during the interviews with Australian participants 
Interviews with director of pharmacy: 
 Current duties, tasks, and functions performed by hospital pharmacy managers 
 Current management of resources, safety, and policies in hospital pharmacy 
 Perceived challenges and problems faced by hospital pharmacy manager in performing their duties 
 Expectations for the future hospital pharmacy practice 
 Possible solutions to identified challenges and threats 
 
Interviews with early career pharmacists and supervisors: 
 Current duties, tasks, and functions performed by hospital pharmacists 
 Opinions about the implementation of policies, safety, and management of resources in hospital pharmacy 
 Perceived challenges and threats faced by hospital pharmacists 
 Expectations for the future development in hospital pharmacy practice 
 Possible solutions to identified challenges and threats 
 
 Results 
Nine hospital pharmacists from New South Wales (NSW) hospitals in 
Australia were interviewed. Out of nine interviews, eight were digitally 
recorded, and one was recorded with field notes. The interviews lasted 
between 30 and 46 minutes, with an average of 40 minutes. Table 2.2 shows 
the characteristics of participants. 
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Table 2.2. Characteristics of Australian participants 
Characteristics of pharmacists n = 9 
Female, n (%) 7 (78) 
Full-time employee, n (%) 8 (89) 
Position, n (%)  
    Director of pharmacy 2 (22) 
    Deputy director of pharmacy 1 (11) 
    Manager 1 (11) 
    Senior pharmacist 3 (33) 
    Pharmacist 2 (22) 
Characteristics of institutions n = 5 
Location, n (%)  
    Major city 5 (100) 
Ownership, n (%)  
    Public hospital 4 (80) 
    Public mental health centre 1 (20) 
Peer group classification, n (%)  
    Principal referral hospital 2 (40) 
    Medium hospital 1 (20) 
    Specialist women’s and children’s hospital 1 (20) 
    Specialist mental health centre 1 (20) 
 
Four key themes relating to the aims of this study were identified: 
“perceptions of current roles”, “opinions about current management of 
hospital pharmacy”, “essential elements in hospital pharmacy”, and “wishes 
and concerns about the future” are described below. Each of themes and 
subthemes is detailed below, with its respective quotes. 
 
 Perceptions of current roles 
Participants outlined their roles and pressures. Different opinions about 
pharmaceutical care and patient-centred approaches in practice were 
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reported. Some participants expressed dissatisfaction in the hospital’s 
expectations of their performance. Misalignment between the institution’s 
aims and hospital pharmacists’ views on pharmacy practice was reported as 
a source of tension in current practice. 
 
 Different approaches to patient-centred care 
Many participants described what it meant to be 'patient-centred'. To have 
direct interaction with patients and be involved in problem solving was an 
aspiration for some participants: 
“My other responsibility is front line management. That's part of my role, 
so face to face contact to patients. I believe it is essential in my role 
even though I'm a manager, I know lot of patients. I feel that's important 
that they see who is involved in that area. So they can address any 
concerns, address any queries.” (A05) 
 
Another participant expressed his preference for a prioritisation model in 
service provision as opposed to equal use of resources for every patient: 
“I think like I said to you before, the general organisation is good if 
nothing goes wrong. It's not, it's all about equal access. [It’s about] 
making sure every patient gets all of the services. That's how it's 
structured. It's all about equality, but it means that the patients that need 
the services the most don't always get most services. So, I would prefer 
a prioritisation model where the high risk patients, that must need it the 
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most, get the most attention, and ones who don't need the most, get 
less attention. But the way it's structured, everybody needs to come and 
get the same level of care which is good at a personal level like if 
people go the same hospital show them the same care as someone 
else, but it's not good at a resource management level because you've 
only got timely management resources and this person may take a lot 
of time, this person is very quick unless they want you to do equal 
things to work, and I feel it'll be better for the patients. The one who 
needs the most services in time had more services in time, and the one 
had less. And so I'll be in opinion that prioritising which patients receive 
what is really, really important. But in NSW, that's certainly not the way 
we work.” (A03) 
 
Interestingly, one participant was upset about an adverse event of 
intravenous medication. The event was harmful and could have been 
prevented by oral medication. Hence, she reported what she believed as 
patient-centred care: 
“I thought I was quite patient centred care until one of my friends came 
to hospital, she had an infection and she was cannulated multiple times 
and had a major bruise on her right wholeful (sic) arm. And when she 
could've been on oral antibiotic she didn't need to have the IV 
canullated in. And I thought, wow that really significantly, she's got this 
major bruise (showing arm) ... She just stayed in, putting in for the 
antibiotic. And I thought, my big campaign at the moment is IV to oral. I 
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thought, this really does make a difference to people. So sometimes 
you think that you're patient centred but really you can do more, and 
you don't realize it.” (A09) 
 
 High work load 
Having a high work load as a hospital pharmacist was commonly described 
by participants. Participants expressed concern when they had to provide 
ward services to a large number of patients concurrently with their 
responsibility to provide dispensing services: 
“If you've got 60 patient load and you only got half of day to do [all] 
wards, I think that's pretty unfair and even for the pharmacist making all 
the manufacturing sterile production by themselves and also do ICU, 
MAU, and a small ward. I think that's quite high load. Even if they're just 
the troubleshooter, so I can see other people are quite stretched, 
especially at the moment.” (A09) 
 
A participant expressed her doubt when they were promoted to take a 
responsibility for a new role without having enough experience: 
“I feel at the moment, because I've never been a preceptor of the intern 
before, because we usually have two interns and this year we have 
three. It's for me, a challenge. I was ready for challenge and the 
change, but it is a big challenge because I feel I'm responsible for these 
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three students. I don't have past experience to kind of back it up on two 
of the other pharmacists who aren't here today, but they have kind of 
work in that role before.” (A06) 
 
One participant also expressed her dissatisfaction with some additional 
administrative duties. The duties were sometimes viewed as time-consuming 
and irrelevant to hospital pharmacists’ roles: 
“The [mother organisation] often sends things that [my Director of 
Pharmacy] has to complete which are very time consuming and they 
are not necessarily, totally relevant to this particular department … They 
asked to fill out, go through the whole poisons list, and for every single 
drugs saying what we were doing about the safety of that drug. Getting 
very specific about [drugs].” (A02) 
 
 Tensions between hospital’s expectations and individual 
responsibilities 
Participants reported there were some gaps between their workplaces’ 
expectations and their own objectives. Different priorities created tensions in 
delivery of services: 
“As an individual practitioner what you want is not always the same as 
what the hospital wants. You want to look after all your patients the best 
way you can, the hospital doesn't really care about all the patients, they 
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care about the majority of patients, the minority to them is minority.” 
(A03) 
They described a ' priority gap' could be manifested in the amount of 
resources and support provided by the hospital, which led to considerable 
work pressure:  
“If you have a number of vacancies, carrying those vacancies put a lot 
of strain on the existing staff, particularly filling weekend rosters and I'll 
just covering work on a day-to-day basis, and that’s truly hard in 
pharmacy because we have to finish the work every day before we go 
home.” (A01) 
 
In contrast, acquiring human resources was not regarded as the solution to 
provide ideal pharmaceutical care, but by closing the gap between what the 
hospitals wanted and what participants sought: 
“You can hire additional 500 pharmacists tomorrow and the question 
will always be, “What's the priority?” ‘Cause there's so many things you 
can do. When it comes to patients' health, you could easily get 20 
professionals looking after 1 patient, because there's so much to do. So 
you'll never going to be staffed well enough, you'll never going to do 
everything, but what's important is to know what the priorities are. And 
then you can at least allocate the appropriate of resources to that 
setting, and again with the most skilled staff for the cheapest amount.” 
(A03)  
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Interestingly, with increasing opportunities for senior roles within the hospital, 
some participants reported others having increased expectations for what 
they should do. Participants expressed this might not be their 'core business': 
“Because I work in a hospital for 7.5 years, I've had a variety of roles 
including education and training and basically rotated to every clinical 
stream as a ward pharmacist. So people often ask me for antimicrobial 
advice, but also just general advice. So to do administrative things like 
payroll if I'm sitting in pharmacy so that distracts me from my core 
business. So I find sometimes I'm constantly being interrupted.” (A09) 
 
2.4.2. Opinions about current management of hospital pharmacy 
A number of issues of importance were raised by study participants. 
Financial management was deemed highly important because the 
expenditure on medicines needed to be carefully managed by hospital 
pharmacy. Participants provided various responses to data management. 
Managing pharmaceuticals was also challenging. Managing people with 
limited resources was described as a challenge. Medication risk 
management was unanimously viewed as hospital pharmacists’ 
responsibility. 
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 Financial management 
Management of costs was reported by participants as a vital aspect of 
pharmacy management. Financial management was deemed very important 
because hospital pharmacy managed valuable material: 
“We buy a lot of drugs and we try to get good prices of drugs so that 
we’re getting, uh, we handle that 50 million dollars with inventory of 
drugs per annum and it's really important that we match those soundly 
and in compliance with key financial performance indicator. So, we do a 
lot of financial management work as well.” (A01) 
 
In a different context, a participant questioned the value of budgeting in drug 
procurement:  
“Our hospital hasn't developed the drug budget because we can't really 
see the value of doing that because if the main pressure of our 
expenditure is the kind of the patient we have, if we accept those 
patients we have to treat them.” (A04) 
 
However, participants also acknowledged that cost-containment was a key 
financial contributor to the hospital because while there were large amounts 
of money involved, there was no revenue generated: 
“In lots of ways our department spends a lot of money because we're 
spending $20 million a year on drugs, plus the cost of running this 
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department, $3-4 million. So, lots of ways of costing, we're important 
part of the hospital. We're not generating funds like radiology or one of 
those other departments. Actually you're getting money from some of 
the services that they provide.” (A04) 
 
 Information management 
Discussing information management topic triggered various responses from 
participants. A participant rated documentation practice as 'poor' at particular 
hospital, but was worried that implementing improvements might require 
extensive paperwork and possibly affect quality of care of patients: 
“Documentation is quite poor, and I do believe of that will improve in the 
future, but if any way if we turn to spend more time on it and that means 
less time with our patients and so your paperwork will probably double 
just so you can make sure everyone know what's going on and happens 
for the medication safety initiatives or have good support from the top 
but the ongoing consequence of that is you have less patient care.” 
(A03) 
 
The use of paper medication charts was either preferred (to electronic 
systems) or perceived impractical: 
“I've always been brought up with the paper chart, like when I was still 
an intern I used that system, to me that's very easy, straightforward and 
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run in front of me, like with the notes, so I really like the paper chart, I 
think that's really good.” (A03) 
 
“Well I have to say I'm an advocate and I am happy with the idea of 
moving towards electronic management and I think that electronic 
management in general for patients, medications, is the way forward … 
I can really slack from the pharmacy … I can just look it in the monitor 
and see what your ward is up in and it's in real time so you're not having 
to chase paper chart.” (A07) 
 
“I just like the fact that we're going to have a system that's very legible. 
We got to know who's prescribing, who's administering, who's 
dispensing, because it's all electronically, there's no handwriting.” (A04) 
 
Moreover, use of computerized data management was generally valued, but 
one participant was not confident with the considerable effort to use the 
technology: 
“[HISs] are labor intensive to both manage and to use, so that’s the 
difficulty with that … I think there's challenges for us all because 
technology will offer us more opportunities for hospital pharmacists to 
be able to provide services beyond dispensing and dealing out with 
product. But, organisation of the technology costs a lot, so there would 
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be challenges for us in making sure it's not stuck in dispensary just 
doing dispensing because it costs too much for the technologies to 
replace the pharmacists.” (A01) 
 
2.4.2.3. Inventory management 
Unexpected shortage of pharmaceuticals was a concern expressed by 
participants. Drug shortages agitated participants because this might limit 
access to essential medicines and this might harm patients: 
“Right now, I've got two drugs we're short. Look at this (showing her 
notes) from my notes. ‘Shortages’ is the first word on my notes. Do you 
read that? Yes, I have [problems with shortage]. I'm going through right 
now. (Sigh) Obviously, my area of interest is antibiotics, but there are 
multiple areas with drugs are short. But it's pretty critical because when 
you don't have access on an antibiotic and you get someone get an 
infection, that's pretty bad.” (A09)  
 
The use of brands and marketing to influence prescribing was reported as a 
concern in managing medications and the associated expenditure: 
“Balancing the pressures from, you know, drug companies obviously try 
to and develop their brand, and you whatever. It's obviously going to be 
expensive and then people hear about it and doctors hear about it and 
doctors want to use it, but we can't keep doing it for, you know, we 
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can't, the government can't afford to provide that for everyone. I think 
that's probably one of the biggest issues. It's just the actual cause of it, 
instead of the cost of drugs.” (A02) 
 
 Personnel management 
Human resource management was reported as a key aspect of management 
in hospital pharmacy. Employment of well qualified staff and ongoing training 
were prioritised, although vacancies did occur: 
“It's also very important to employ the right people. So, I'm very careful 
who I employ because it's very hard to get rid of people. I don't mean 
get rid of that but if people aren't performing, you must always employ 
the right people. And not just the person to do a job. So, I'm very careful 
if I'm not, at all concern of this person, may not be the right sort of this 
over here, then I'd rather leave the position unfilled and re-advertise. 
Because it's very important, because if we put a lot of effort into training 
someone, it takes a long time to get someone, whether it's a pharmacist 
or technician, off the street to working to the stage that we want. And 
that's a lot of time and effort we have put in our department.” (A04) 
 
Participants expressed some dismay at hospitals' cost-containment 
strategies which could delay staff recruitment: 
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“The hospital is always trying to save money and sometimes money 
saving strategy to the recruitment as long as possible to save money.” 
(A01) 
 
A participant expressed her dissapointment when losing a highly specialized 
staff member: 
“I think that would be probably challenge in the area, losing, when you 
have such a specialized area and you lose staff who really specialized 
and really know a lot about an area, it can be really felt. So, that's 
probably one of the biggest changes. I think staff really impact on 
working place.” (A07) 
 
The participants reported their concerns, as managers, regarding balancing 
the sense of fulfillment for their own staff with the levels of achievement of 
the organisation: 
“We are all in the workplace to do what the hospital wants us to do and 
people got their own personal development and career aspirations, so 
getting people to understand the balance of what the organisation 
expects them to do to us and then for us to give something back to 
them and managing those expectations is challenging sometimes.” 
(A01) 
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 Risk management 
Participants expressed concerns regarding potential risks associated with 
medication management. They were concerned about mismatch between 
wards’ requests and what pharmacists deemed as efficient and safe: 
“The wards might often try and say, “Oh we want this, we want that,” 
they think they're using a lot of it. But if it's, we have to think of the 
costs, the safety, so for instance we don't want potassium ampules on a 
particular ward or on the wards that doesn't know the cost, safety and 
sort of usage.” (A02) 
 
A participant was also concerned with limiting drug supply to wards because 
it could put patients at risk in an emergency situation: 
“Obviously the risk of taking out imprest means people who need it 
timely first dose of antibiotic like in a septic patient might have easy 
access to it, after hours especially.” (A09) 
 
The lack of engagement of patients in the approach to medication safety was 
reported as a major challenge in medication safety management in Australia: 
“[Medication safety] is everyone's responsibility, the nurses' 
responsibility, the doctors' responsibility, it's the patients' responsibility 
and the thing that most possible struggle within Australia is really 
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getting the patients responsible and more involved in that task. So, 
consumer engagement is really important, but rarely happens.” (A03) 
 
There was support for in the way in which incidents were managed, as a part 
of a practice improvement program: 
“Yeah there was an incident that happened on one of the wards to do 
with antibiotics that a nurse told me about and I asked her to put it in 
IIMS and then she was worried the person would get in trouble. But I 
said we're pharmacy, we don't blame people, we try to look out how can 
we improve, like we'd never look at it, we don't get offended by people 
putting incidents in.” (A09) 
 
2.4.3. Essential elements in hospital pharmacy 
Perceived key factors in hospital pharmacy management and practice were 
reported. The necessity for a specific skill set for hospital pharmacists was 
emphasized. The importance of leadership was highlighted. Finally, changes 
in current system to improve patient safety, data management, and service 
quality were expected. 
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2.4.3.1. Competencies 
Participants described what they needed to know, to be able to work as 
hospital pharmacists. Awareness of roles was reported as a fundamental 
element to define what was required of hospital pharmacists: 
“The basis [to develop our procedures] is knowing the business. So, we 
have to know what your role is in this institution. So, in this institution I 
supposed, as in many hospital pharmacies, you have a certain group of 
medication that you're dealing with and a certain population. So, it 
means area I would have, say, guidelines to the types of patients, the 
types of drugs that can be developed.” (A05) 
 
Relevant hands-on experience in community pharmacy was also deemed 
essential if junior pharmacists decided to enter hospital work: 
“I think a lot of people going into pharmacy should [have hands on 
experience in community pharmacy] because that's where the majority 
of the work here. I think it gives people real insights as students or 
maybe they can work as pharmacy assistant or just be in touch with the 
community pharmacy before they take on pharmacy, I think it's good 
experience.” (A07) 
 
In early career years, regular duties were regarded as routine; this 
experience in various roles was highly appreciated by participants: 
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“I guess with pharmacy you can be quite, Monday to Friday you're in 
dispensary, be it outpatient or inpatient, but here I've been given the 
opportunity to act in senior role. I have a whole different array of wards, 
you know, from geriatric to adolescent so variety I think is good, not the 
same thing every day.” (A07) 
 
2.4.3.2. Leadership 
To have effective leadership was identified as an important issue in 
managing hospital pharmacy. Participants identified the importance of trust 
between managers and pharmacy staff: 
“Umm, well, I think [one key element is] awareness. So being aware of 
what the duties of all the staff really are, and then being fair about that. 
(Thinking) I supposed, openness and (sigh) being consistent, so ideally 
having everybody aware of, sometimes people might complain, "Oh I've 
got 4 hours in the dispensary and that person only gets one!" But if 
everybody's aware that person got other duties as well, and may be a 
more complicated ward, making sure that everybody realizes that sort 
of things. Also making people feel that they can come to you and talk 
about any problems they have.” (A02) 
 
A leader was also expected to influence people, particularly in a changing 
environment: 
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“You need to engage people because they're the ones prescribing it, 
you can't just change it on paper because no one will follow it … you're 
not like the policemen or the dictator that tells people you must 
prescribed this because this was in the guideline, we found it really 
effective from them to change from the inside out.” (A09) 
 
It was essential for a hospital pharmacy leader to be involved and be a role 
model for others: 
“I usually try and attend those meetings because I think that’s important 
for me to be a good role model for continuing professional development 
and to be involved and to hear the research presentations or the clinical 
presentations or the things that may be discussed at our clinical 
meetings, and for me to be up to date with clinical things as well as 
management things.” 
 
2.4.3.3. Organisational behaviour 
Supportive organisational culture and behaviour were perceived key factors 
in success. Some participants expressed dissatisfaction with current 
organisational cultures, and changes sought changes:  
“I think that we as a department here will really need to change the way 
we do things. At the moment things are quite segmented, but I feel that 
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there's a lot of changes can be made that will make us more efficient. 
And we'll reduce the level of stress on pharmacists.” (A06) 
 
Bureaucratic environments vexed participants because it was deemed as a 
hindrance to change: 
“I guess like within the health care institutions, cause there's always 
multiple level of hierarchy, people I have to go through, if there's 
something that I think needs to be changed, policy, procedure-wide, 
those changes can take 6 months to actually happen coz it's got to be 
approved by 70 different people above.” (A03) 
 
Participants had strong expectations of high quality, safe, and appropriate 
care provided by hospital: 
“My expectations which I feel extremely strongly firm, I've had two 
friends in hospital, and saying things first hand. Is it okay to be patient 
centred? Not just bureaucratic. And my expectations would be high 
quality but also safe, appropriate and quality care … Bureaucratic is just 
doing things because paperwork says so.” (A09) 
   
Interestingly, one participant who was working in a small hospital expressed 
contentment because in working with a relatively small subset of medications 
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she felt she had a comprehensive knowledge of those medicines, and was 
thus more confident: 
“I have to say having worked here in my 3rd year I feel quite confident 
with medications and definitely it's a small sub set of medications so 
you don't need to see larger sub set of medications.” (A07) 
 
2.4.3.4. Rigid system 
Supportive hospital environment to support pharmacy practice was 
described. Reflection on international experiences in hospital pharmacy 
practice identified some areas of new interest, for example, benefits 
associated with the application of barcode scanning: 
“America's been through [barcode scanning]. It was until the FDA 
required the manufacturers provide barcode of that detail, that they 
really start to utilize a lot of this medication safety equipment. So, that's 
something that we need to move towards, but that's going to be a 
journey. And it's probably a whole of nation thing that we have to do.” 
(A04) 
 
An evidence-based approach to implementation of new services was 
described as being expected to avoid bias and emotional attachment in 
decision making: 
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“Data is always good. That's where orders, feedback to come back, 
literature reviews, just try to keep it not emotionally attached, don't take 
things like, "We always do that, that's always fine." Just show them the 
data and say, "Look, in last 6 months you have these many patients, 
you'll see this, and the current literature supports this. And you just keep 
everything as aim as biased for it as possible. And use a lot of data and 
I think data speaks for itself. Usually it's much easier. But if you don't 
have data, I think it's just a bit of a classic opinions throughout the time.” 
(A03) 
 
Concerns over observed mismatched expectations between patients and the 
government funding schemes was reported, indicating that clear and patient-
centred policy was desirable to participants:  
“Managing patients' expectations as well can be challenging. 
Sometimes the underpinning policies that we have to work with about 
providing medications is difficult for patients to understand and they're 
not always good policy, sometimes there’s difficulties between the state 
and the commonwealth about how they want to manage the drugs and 
there's a bit of cost-shifting and patients can’t understand.” (A01) 
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2.4.4. Vision and concerns for the future 
Participants reported their vision and concerns for the future of hospital 
pharmacy. Participants had a strong view on the need for professional career 
development and appreciation of their expertise within the hospital sector. 
However, participants also projected perceived future challenges, such as 
insufficient funds. Furthermore, participants provided a range of perspectives 
about the future, for example excitement of future technology and staff’s 
resistance to change. 
 
2.4.4.1. Career development 
Strong opinions about the future of hospital pharmacy practice were reported. 
A proactive attitude was thought to open up career opportunities: 
“Sometimes to have career development, I think you really need to 
carve your own way. So, I think that you have to look for opportunities. 
You kind of have to make a niche.” (A07) 
 
In addition, there were optimistic attitudes regarding future opportunities and 
roles: 
“We're very lucky in hospital pharmacy. Community pharmacy has a lot 
of issues with the price for. They're underpaid, skills are not being 
utilized. Hospital pharmacists are the opposite. We get paid very well, 
and the amount of positions in hospital pharmacy is increasing every 
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year … it feels to me that pharmacist are going to have a greater role 
high up in regards to project management, policy directives.” (A03) 
 
However, to take up greater roles in the future, there were expectations for 
pharmacists to contribute in different areas in health care: 
“I think hospital pharmacists need to be a bit more outward looking as 
well and to get jobs doing other things in health, so that people at high 
levels in the health system have a better understanding about the 
potential contribution that hospital pharmacists can make.” (A01) 
 
For senior pharmacists who were considering their retirement, they 
considered the legacy they would leave behind:  
“[My future direction is] retirement. (Laughing) I'm easy on that one. I 
just want to make sure that I leave, there's a suitable legacy, that I leave 
a legacy and one of the legacy I hope is just to be able to communicate 
to most of the, not only with people responsible in the hospital, but also 
with the patients. I just want to make sure that our staff, especially our 
juniors, get the opportunities to take on that to extend their role.” (A05) 
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2.4.4.2. Professional appreciation 
Participants were concerned for the future of their profession. A participant 
expressed concern over professional identity hospital pharmacists ought to 
establish in the future: 
“Our role has always been expanding and it's becoming very clear to a 
lot of people that pharmacists are very good use of resource, we can do 
a lot of things. And that's what makes the future of hospital pharmacy 
very bright, but the question has always been, “Is there anyone cheaper 
who could also do the job?” That's always going to be, I guess, the 
challenge that pharmacist's going to face, to say not only the best but 
no one else can do this.” (A03) 
 
Furthermore, without stimulating environments and appropriate 
remuneration, potential successors might leave their roles: 
“Here's a lot more opportunities for pharmacists these days to do 
different things. If we can’t provide people with a good environment and 
appropriate umm (paused) remuneration, the leaders that we want to 
get will come to other things.” (A01) 
 
Additionally, lack of career progression opportunities to higher positions 
concerned participants: 
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“Some people will say to you that it's very hard to move up in the 
hospital pharmacy, it's not because there's a lack of direction, it's just 
because people need to retire or people need to move on for you to get 
those jobs.” (A03) 
 
2.4.4.3. Not enough funds 
Access to funds in the future was worrying for participants. Uncertainty with 
financial viability in the future was felt by participants: 
“There's not enough money in the system to be able to deliver those 
things. There's less people paying taxes so the money constraints are 
gonna get higher. A lot more health is being privatized. People want to 
make money out of privatized health. So that's more challenging 
because it will cost more as well. And that's the constraint will become 
more about public health will be central private system, and that's 
gonna cost a lot more money.” (A01) 
 
The feasibility of expanding services was questioned in an uncertain financial 
future: 
“We have lot more expansion that we can do, but we're limited by the 
health systems in terms of, I'm not generating resources to pay for my 
own activities. A lot of my activities are in terms of safety, providing a 
quality. They're not generating funds.” (A04) 
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2.4.4.4. Different attitudes toward changes 
There was diversity in attitudes towards potential future development of 
hospital pharmacy. Some participants were enthusiastic to participate in 
change, particularly in information management: 
“[The dispensing software] is coming. I know it's coming. And it paired 
to do with our resource which is medical record. So once our medical 
records have gone electronic, so that is the next phase. So, once i-Soft 
develop the outpatient and I believe it's coming.” (A05) 
 
However, another participant reported her doubt because of previous 
experience of staff being resistant to change: 
“It is not easy to change procedures, especially with staff who may be 
less keen to take up changes.” (A08) 
 
2.5. Discussion 
As outlined in the preamble, this paper aimed to explore Australian hospital 
pharmacists’ perceptions of their responsibilities, challenges and key factors 
in managing pharmacy, as well as to explore potential future development. 
Hence we explored key informants’ experiences and opinions within this 
qualitative study. Our findings suggest that there are constant tensions 
between what hospital pharmacists wish to achieve and what the institutions 
might expect them to achieve in their roles as hospital pharmacy managers. 
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There may be tensions based on a mismatch between hospital pharmacists’ 
underlying values and perceptions and the hospital expectations for hospital 
pharmacy service. As a result, work dissatisfaction and frustration may occur 
and were described in this study. 
 
 Perceptions of current roles 
It appears that although participants described the wish to be 'patient-
centred' in their approach, there was ambivalence regarding how to be 
patient-centred in their practice. Some participants believed that being 
patient-centred was to have direct involvement in patients’ medication 
management. Other participants believed that patient-centred care was to 
provide services to selected, highly prioritised patients. Another participant 
suggested patient-centred care as a non-bureaucratic, safe and appropriate 
care. The literature has shown that there are different perspectives on this 
and therefore this is not surprising in this context (12, 13). Although it 
deemed beneficial to seek a “well-defined identity and a clearly articulated 
purpose” of a profession (12), those equivocal ideas still appear seem 
relevant and challenging to define a clear definition of pharmacists’ 
responsibilities. 
 
Furthermore, those equivocal ideas of pharmacists’ ideal roles are 
sometimes mismatched with hospitals’ expectations. Participants often 
described feeling high pressure at work, with little support from the hospital 
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executive. Work dissatisfaction in this situation may not be surprising.(7). 
However, even lack of staff shortages, without clear definition of pharmacists’ 
roles and aims may lead to frustration and tension in the workplace. 
Moreover, this study suggests that prioritisation may be key to optimising 
limited resources in increasing demand of care. This suggests that 
management is inseparable from pharmacy practice. However, pharmacy 
management may not be a clear focus for many students and practitioners 
because there is a perception that pharmacist is a clinical purist (5). Setting 
management apart from pharmacy practice may lead to limitations in 
achieving patient-centred care. The understandings by hospital staff about 
“patient-centred” care may merit further study. 
 
 Opinions about current management of hospital pharmacy 
Our study suggests that our participants endorsed their roles to include 
managerial responsibilities. The following areas of management were 
acknowledged by participants as hospital pharmacists’ responsibilities: 
financial, information, inventory, personnel, and risk management. 
Pharmacists’ managerial responsibilities are pictured comprehensively in the 
national competency framework (14). This framework integrates pharmacist 
accreditation, training, and education in Australia.  
 
However, there are conflicting opinions about how a hospital pharmacy 
should be supported technically. For example, some participants were very 
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enthusiastic with electronic systems, but some others preferred paper-based 
documentation. Such opinions were rooted in participants’ own experiences, 
beliefs, and appraisal of the benefits and efforts of a particular management 
activity. Furthermore, as reported by Hodnette, underlying beliefs about 
something can also play a significant role in the ultimate success or failure of 
the information system and facility itself (15). Our findings also suggest that 
hospital pharmacists perceive that they lacking influence on the management 
of the pharmacy. Terms such as “insufficient funds”, “shortages”, 
“understaffed”, “lack of consumer engagement” indicate some external, 
perhaps inevitable, and uncontrollable pressures on pharmacists’ managerial 
responsibilities. The findings also suggest that pharmacists might be 
excluded from certain decision making processes. 
  
WHO recommends hospitals to establish a multidisciplinary team – known as 
Drug and Therapeutics Committee (DTC), to develop the hospital formulary, 
review medication use, and develop policies related to use of medicines in 
hospital (16). In Australian hospitals, pharmacists are part of DTC 
stakeholders (17). It may be beneficial if pharmacists can have deeper 
involvement in DTC, thus DTC roles may not be limited only to 
pharmaceutical use, but also to how pharmacy is managed. More 
understanding about potential DTC roles in pharmacy management may be 
explored further. While this is routine in Australian hospitals, this experience 
may vary internationally. 
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2.5.3. Essential elements in hospital pharmacy 
The results suggest that participants were aware that hospital pharmacy is a 
part of a larger entity – the hospital, thus both hospital pharmacists and 
hospital setting had to have particular characteristics. To deliver optimal 
pharmacy operations, both the profession and the environment should be 
conducive. As professionals, pharmacists have considerable autonomy to 
provide care for patients (18). Pharmacists’ competencies and pharmacy 
leadership were recognised by participants as essential factors in the hospital 
environment. 
 
Nevertheless, when pharmacists are employed by hospitals, the degree of 
autonomy varies according to the culture, behaviour, and type of the 
organisation (5). Consequently, it is not surprising that participants were not 
happy with particular organisational structures and cultures, described as 
'segmented', 'hierarchical', or 'bureaucratic'. In a different context, 
participants valued their involvement in development programs, 
specialisation and small-sized organisations, and valued their opportunities 
for evidence-based and accountable practice. It suggests that professional 
autonomy may increase in a small and specialised teams where the 
members of the team share similar values and promote accountable practice. 
The result also supports previous study finding that, although in 
multidisciplinary teamwork professional autonomy was reduced and was 
influenced by members’ attitudes, it led to an increase in professional 
accountability toward the multidisciplinary team goals. (19). Further 
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investigation about hospital pharmacy autonomy and teamwork quality may 
merit considerable understanding of educators, researchers, practitioners, 
hospital executives, and policy makers about defining pharmacists’ roles in 
hospital environment. 
 
2.5.4. Visions and concerns for the future 
Many expressed their wishes and concerns for pharmacy leadership. 
Participants wished for zealous pharmacists to emerge and forge their way to 
leadership in the health system. A desire for a greater role in, and 
contribution to, the health system was strong, albeit their expressed concerns 
about unsupportive environments for future leaders. For example, having 
fewer leadership positions for hospital pharmacists, less recognition of the 
pharmacy profession, less financial support, and resistance to change, which 
were reported by participants, may limit pharmacists' interest in staying in the 
profession. Furthermore, it may hamper hospital pharmacy development in 
the future.  
 
Succession planning was also wished for and was recognised as important to 
prepare future leaders. This result enriches a study conducted by White in 
2005, where the researcher investigated a potential crisis in pharmacy 
leadership in the US. The writer of that report recommended some actions to 
prepare individuals and professional organisations, where succession 
planning was emphasized (20). This observation suggests a necessity for 
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Australian practitioners and professional organisations to become proactive 
in succession planning and developing a supportive environment for a viable 
profession. 
 
In Chapters 3 – 5, Stage 2 of this research exploring hospital pharmacy 
management in the Indonesian context are described. 
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3. Indonesian Hospital Pharmacists’ Roles 
 
 
Background: The importance of the rational use of resources and avoidance 
of wastage in pharmaceutical management have been national concerns in 
developing countries, such as Indonesia. With a strategic role to apply and 
promote pharmaceutical care and rational use of medicines, hospital 
pharmacists have a strong potential to improve efficiency in healthcare. 
Objective: The aims of this study were to explore Indonesian hospital 
pharmacists’ perceptions of their roles, barriers and enablers of such roles, 
and to describe potential relationships among practice philosophies, practice 
models, and pharmacists’ attitudes.  
Methods: Qualitative research was undertaken involving semi-structured 
interviews. Constructivist grounded theory was adopted to generate key 
themes.  
Results: A total of 31 pharmacists were interviewed. Hospital pharmacists 
deemed themselves as medicine experts who were responsible for clinical 
service provision, but described that existing distributive and administrative 
roles were predominant. A range of attitudes toward managerial roles was 
expressed, with majority of participants expressing frustration. Both the 
external environment and factors internal to the hospitals were highly 
influential on their ability to achieve their clinical and administrative roles. A 
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model linking perceptions of roles, attitudes and practice models was 
developed.  
Conclusion: Indonesian hospital pharmacists believed that pharmaceutical 
care was essential for patient-oriented care. However, multiple interpretations 
of 'patient-oriented' and 'pharmaceutical care' were described. This was 
reflected in varying extent to which pharmacists accepted or 'refused' roles 
and responsibilities. Indonesian hospital pharmacy may face significant 
challenges and/or develop different pharmacy services for the future. 
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 Introduction 
Rational use of medicines has been a major concern across the globe and 
WHO has estimated that up to half of medicines prescribed are appropriate 
(1). Inappropriate prescription of medicines reduces the quality of care and 
efficiency in health care (2). Rational use of resources and avoidance of 
wastage in pharmaceutical management in public healthcare settings have 
been identified as national concerns in Indonesia (3). In Indonesia, around 
70% of hospitals are governmental hospitals (4). Less is known about 
efficiency data in private hospitals. Furthermore, in this country hospital care 
services accounted for 60% of total healthcare expenditure (3). Therefore, 
hospital pharmacists have a strategic role to apply pharmaceutical care and 
rational use of medicines in this setting to improve efficiency in healthcare. 
 
In 2007, the FIP conducted worldwide surveys to explore hospital pharmacy 
practice. The results suggested that practice models were implemented to 
varying degrees, and access to essential resources was diverse among 
participating countries (5). A meta-analysis showed that hospital pharmacies 
lacked clear definitions of pharmaceutical care across the globe (6). Although 
diversity was shown, hospital pharmacy leaders outlined a consensus vision 
of hospital pharmacy practice, known as the Basel Statements (7). Hospital 
pharmacists are expected to take roles to ensure responsible use of 
medicines, to achieve timely and efficient access, in collaboration with other 
health professionals (8).  
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However, the role of hospital pharmacists may vary across the world. In 
developed countries pharmacists’ responsibilities have shifted from drug-
distribution roles to a focus on more clinical, patient-oriented care (6), but in 
many low-middle income countries, hospital pharmacists predominantly 
performed managerial functions (5). These changes were influenced by 
country-specific factors. For instance, in the US, medicine distribution roles 
have been taken over by pharmaceutical automation, so pharmacists have 
been able to expand their roles to be more clinical (8). Patient-oriented care, 
also known as ‘pharmaceutical care’, has different interpretations and 
implementation across the globe (6).  
 
In 2014, Indonesia reformed the national health insurance system, changing 
health service delivery (9). These changes may lead to some potential 
threats or opportunities for redefining the role of the hospital pharmacist in 
Indonesia. There are apparent differences between developed and 
developing countries, in terms of capacity, challenges, and demands for 
pharmacy services.  
 
 Objective 
This study aimed to explore Indonesian hospital pharmacists’ perceptions of 
their current roles, barriers and facilitators to perform such roles; and 
potential relationships among practice philosophies, practice models, and 
pharmacists’ attitudes. 
 75  
 Methods 
An inductive, qualitative approach was adopted to conduct this study. Given 
the aim of this study was not to generalise the findings, but rather to gather a 
holistic understanding the phenomenon and issues, a qualitative research 
approach was deemed appropriate. There are several characteristics of 
qualitative research which fit the purpose of this study, such as it focuses on 
learning the meaning held by participants about a particular issue, where 
data is collected in the participants’ work context and natural setting (10). 
 
3.3.1. Participants 
Purposive and convenience sampling of participants from five provinces in 
Indonesia (DKI Jakarta, East Java, South Sumatera, Riau, and Banten) was 
undertaken. A purposive approach was utilised to identify and interview key 
informants from hospitals, government, and the professional pharmacists’ 
association in Indonesia (Indonesian Hospital Pharmacy Interest Group, of 
the Indonesian Pharmacists Association). Initially key informants were invited 
with an invitation letter (Appendix 3.1) and a consent form (Appendix 3.2), 
then a snowballing technique was adopted to recruit subsequent participants. 
Interviews were conducted between February and April 2015. 
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3.3.2. Data collection 
Key topics were explored using an interview guide that consisted of open-
ended questions (Table 3.1). To design the interview guide, we consulted the 
existing literature about hospital pharmacy management (11), and piloted the 
interview questions. The interview guide (Appendix 3.3) was designed with 
questions for hospital pharmacy managers and early career pharmacists, to 
include different perspectives in hospital pharmacy management, as 
experienced by participants. Interviews were conducted in places and times 
convenient for participants. Participants provided informed consent and 
interviews were digitally audio-taped and extensive field notes were taken by 
the researcher. For participants who did not wish to be recorded only field 
notes were taken. The interviews were conducted by VG. 
 
Table 3.1. Topics covered in semi-structured interviews with Indonesian participants 
Interviews with Directors of Pharmacy: 
 Current duties, tasks, and functions performed by hospital pharmacy managers 
 Current management of resources, safety, and policies in hospital pharmacy 
 Perceived challenges and problems faced by hospital pharmacy manager in performing their duties 
 Expectations for the future hospital pharmacy practice 
 Possible solutions to identified challenges and threats 
Interviews with early career pharmacists and supervisors: 
 Current duties, tasks, and functions performed by hospital pharmacists 
 Opinions about the implementation of policies, safety, and management of resources in hospital pharmacy 
 Perceived challenges and threats faced by hospital pharmacists 
 Expectations for the future development in hospital pharmacy practice 
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 Possible solutions to identified challenges and threats 
Interviews with members of the government and professional association 
 Development of standard of practice and its implementation 
 Perception of ideal hospital pharmacists’ roles 
 Opinions about current hospital pharmacy practice 
 Perceived key elements in managing hospital pharmacy 
 Future expectations and perceived challenges in hospital pharmacy 
 
3.3.3. Data analysis 
The interviews were transcribed verbatim. During the data collection period, 
each transcript was analyzed for emerging themes. This technique was used 
to summarise emerging issues and also identify issues that needed further 
probing in subsequent interviews in order to gain comprehensive data. In this 
study saturation was considered to have been reached when no new themes 
emerged in three consecutive interviews. Analysis was performed in a 
constructivist grounded theory approach (10). Given the purpose of this study 
was to explore participants’ perceptions of their roles, constructivist approach 
was regarded as appropriate because it explores important topics highlighted 
by participants. Identification of themes was performed using holistic coding, 
descriptive coding, and pattern of codes was identified with focused coding 
(12). 
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3.3.4. HREC Approval 
This research was approved by the Human Research Ethics Committee of 
the University of Sydney (Project number 2014/680). 
 
 Results 
A total of 28 hospital pharmacists, 2 pharmacists from government bodies 
and 1 pharmacist from professional body were interviewed between February 
and April 2015. Out of 31 interviews, 24 interviews were audio-taped, and 7 
interviews were recorded only with field notes. One interview was conducted 
with multiple participants because they were able to present at the same time 
and place during the interview. Two interviews were conducted by telephone. 
The interviews lasted between 15 minutes and 80 minutes, with an average 
of 45 minutes. Table 3.2 shows the characteristics of participants.  
 
Table 3.2. Characteristics of Indonesian participants 
Characteristics of pharmacist participants n = 31 
Female, n (%) 25 (81) 
Full-time employee, n (%) 31 (100) 
Position, n (%)  
    Director of Pharmacy 10 (32) 
    Deputy Director of Pharmacy 2 (6) 
    Supervisor 10 (32) 
    Pharmacist or clinical pharmacist 4 (13) 
Other (logistician, head of clinical department, director of pharmaceutical directorate, member of pharmacy council, secretary of professional body) 5 (16) 
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Characteristics of institutions n = 21 
Province, n (%)  
    Banten 1 (5) 
    East Java 5 (24) 
    DKI Jakarta 9 (42) 
    Riau 1 (5) 
    South Sumatera 5 (24) 
Ownership, n (%)  
    Government body 2 (10) 
    Public hospital 8 (38) 
    Private hospital 8 (37) 
    Private non-profit hospital 2 (10) 
    Professional body 1 (5) 
Hospital class, n (%)  
    Class Aa 7 (33) 
    Class Bb 9 (43) 
    Class Cc 2 (10) 
    Non-hospital 3 (14) 
Types, n (%)  
    General hospital 9 (43) 
    Provincial general hospital 4 (18) 
    General hospital centre 1 (5) 
    National general hospital centre 1 (5) 
    Cancer hospital 2 (10) 
    Mental health hospital 1 (5) 
    Non-hospital 3 (14) 
a  Referring to hospitals with adequate facility and resources for at least four basic specialisations (internal medicine, paediatric, surgery, and obstetrics and gynaecology), five ancillary services, 12 other specialisations, and 13 sub-specialisations  
b  Referring to hospitals with adequate facility and resources for at least four basic specialisations, four ancillary services, eight other specialisations, and two sub-specialisations 
c  Referring to hospitals with adequate facility and resources for at least four basic specialisations and four ancillary services 
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Four key themes relating to the aims of this study were identified: “current 
hospital pharmacists’ roles”, “hospital pharmacists’ managerial roles”, 
“barriers to perform hospital pharmacists’ roles”, and “enabling factors to 
perform hospital pharmacists’ roles”. Each of these themes and subthemes 
are discussed in detail below. A model linking perceptions of roles, attitudes 
and practice models was also developed. 
 
3.4.1. Current hospital pharmacists’ roles 
The study respondents reported details of their roles in hospital pharmacy. 
The majority of participants described their belief that hospital pharmacists 
had to prioritise clinical services for their patients: 
“I will prioritise my patients, so clinical services are considered as more 
important than administrative tasks.” (P3) 
 
Participants also positioned themselves as medicine experts: 
“When it comes to drug interaction, pharmacists know better than 
doctors, so they should be glad when we share information on that … 
When I talk with [my staff] and explain everything they end up willing to 
sacrifice their personal needs and agree to work overtime.” (P15) 
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Furthermore, participants perceived that the hospital pharmacist is a part of a 
multidisciplinary team: 
“I am also communicating regularly with doctors, nurses, other 
pharmacists, and other people in the hospital; I am not surprised to 
meet people. Because I sometimes accepted phone calls from unknown 
people asking me about medicine information, then I would help them 
too.” (P22) 
 
Some respondents reported that while they performed both drug distribution 
and clinical roles, administrative roles would be predominant: 
“[My clinical pharmacist] focuses more on administrative tasks. So I see 
her roles are not explored deeply.” (P8) 
 
However, some participants reported a separation of clinical and drug 
distribution responsibilities: 
“I explained that [shortages] are not my responsibility as a ward 
pharmacist …. Shortage of medicines is purchasing department’s 
responsibility.” (P1) 
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3.4.2. Hospital pharmacists’ managerial roles 
When asked about management topics, participants’ responses varied. Many 
participants defined management as inventory management. Most 
participants emphasized their responsibilities for operational management. 
Essentially, few respondents expressed the importance of managing 
pharmaceuticals and revenue: 
“Management of tens of percent of hospital money is here. If this is not 
managed well; drugs are expired, unused, wasted … I still believe that 
hospital pharmacy is hospital’s main source of money. We can’t avoid 
that fact. As long as I can be efficient, I will do it. For private hospital, 
this is still major source of revenue.” (P7) 
 
Many participants reported their responsibilities for service provision: 
“I will look through [depots’] compliance with hospital accreditation 
standards, especially in regards to storage condition, UDD 
implementation, or other activities.” (P5) 
 
There were also few participants who reported strategic roles and actions in 
managing hospital pharmacies: 
“I am also the secretary for Pharmacy and Therapeutic Committee. As a 
secretary, I have to put the committee in motion and have to sort out 
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new drug proposals … I plan and do strategic programs that aim to 
achieve the vision and mission of this hospital.” (P31) 
 
Numerous participants perceived managerial roles as burdensome, and 
expressed intentions to leave managerial roles in the future: 
“I am planning to return to geriatric and palliative care unit as a clinical 
pharmacist because I won’t have any burden and managerial 
responsibility for my subordinates’ welfare.” (P31) 
 
3.4.3. Barriers to perform key hospital pharmacists’ roles 
Some impediments to performing professional roles were reported. Firstly, 
poor career rewards seemed to be associated with a loss of enthusiasm in 
hospital pharmacy: 
“In this hospital, I can’t level up my career. Pharmacists can only get up 
to level nine. Even though they work until 100 years, they will still be 
there.” (P6) 
 
In addition to that, the presence of 'office politics' concerned some 
participants: 
"There have been cases where the bold ones were victimised … You 
want to do the right thing, but the majority around you don’t, so you’ll 
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end up taking a beating ... I took an oath, I only want to serve patients 
to the best of my ability, but when I am faced with politics even though I 
know the right thing to do I can’t do it because of other considerations. 
So it is very difficult." (P24) 
 
The current Indonesian health system and regulations were deemed as 
'external hindrances' and were highlighted by some participants: 
“I think our government’s regulations have the most significant 
influence. If we don’t have that many options for treatment, we can 
focus more on drugs’ effects. It will solve so many problems here. We 
only need to talk about how many of this drug I need to supply, but not 
supply 3 boxes of brand A and 2 boxes of brand B of the same active 
ingredients.” (P7) 
 
“We control the items because there’s a change in Indonesians’ 
insurance system. Before this, whatever we gave to patients would be 
reimbursed [by the government]. Now, whatever we give to patients, we 
will only receive this certain amount of money.” (P7) 
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3.4.4. Enabling factors to perform hospital pharmacists’ roles 
All participants reported some enablers for hospital pharmacists. Hospital 
accreditation was believed to bring a positive influence on the culture of work: 
“I feel that there is a change in regards to the centre of the hospital. In 
the past, doctors are centre of attention in hospital, but now especially 
after hospital accreditation, it became patient-centred.” (P5) 
 
Some participants also highlighted the need for managerial skills: 
“Managerial skills are important. It’s not limited to personnel 
management only, but it also includes logistic management. If we don’t 
know about that, we can’t manage a satellite properly. We don’t know 
how to identify slow moving, dead stock. Those drugs are not ours, but 
they are our responsibilities. We have to know them. Even we need to 
concern about billing and administration … Managerial skill I mentioned 
before also includes time management. We have so much work to do, if 
I can’t manage my time well, I will feel burdened.” (P22) 
 
Furthermore, some management supporting tools, such as dispensing 
equipment, computerised systems and strategic management tools, were 
also reported to assist their roles: 
“Tubes are used for emergency purposes, where we must supply drugs 
in less than 15 minutes.” (P8) 
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“I am happy because [our information system] is web-based; so if 
there’s any problem when I’m home, I can access it. That’s very helpful 
for us as a supervisor.” (P22) 
 
“We have a quinquennial strategic plan that we develop using balanced 
scorecard. The strategic plan then will be our reference in developing 
hospital pharmacy’s strategic plan … We also establish the strategic 
plan based on stakeholders’ expectations and future directions. After 
that, we will set our vision and missions, and perform SWOT analysis, 
after that I will make a strategy map.” (P31) 
 
3.4.5. Relationships among philosophies, practice models, and pharmacists’ 
attitudes 
A model of relationships among participants’ philosophies of care, current 
hospital pharmacy practice models, and participants’ attitudes was sought. 
The philosophy was based on what the participant valued in his/her roles and 
practice. The practice models were divided into two categories, where the 
participants were clinical pharmacy specialists or generalists. The attitudes 
were those expressed by participants when reporting their roles. The model 
is shown in Figure 3.1. 
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Figure 3.1. Relationships among philosophies, practice models, and hospital pharmacists’ attitudes in Indonesia 
  
 Discussion 
The findings of the present study suggest that all respondents adopted a 
philosophy of pharmaceutical care to some degree. The philosophy was 
reflected in the National Standard of Practice, which defines that 
pharmaceutical care is “a direct and responsible provision of pharmaceuticals 
for the purpose of achieving definite outcomes and improve a patient’s quality 
of life” (13). The definition aligns with Hepler and Strand’s definition of 
pharmaceutical care (9). However, different interpretations of patient-oriented 
care were described by our participants. The participants reported 
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philosophies and perceptions of care that seemed to determine their attitudes 
towards their roles in hospital pharmacy.  
 
Different perceptions of patient-oriented care also seemed to vary among 
participants. In a specialist-centred model of practice, clinical function is 
separated from managerial function, and this appeared to create a 
fragmented culture. Few participants believed that management was an 
essential role for patient-oriented care. Some participants viewed direct 
clinical service provision to patients as valuable patient-oriented care, 
whereas non-clinical, managerial functions were seen as menial inventory 
tasks. Hence, they would prioritise clinical services, but refused to take the 
responsibility when drug shortages occurred. This is consistent with the 
Standard of Practice, which defines clinical pharmacy services as '…direct 
pharmacists’ provision to improve therapy outcome…', and separately 
defines management as 'inventory and risk management, with limited 
expansion to personnel and capital management' (13). There seems a lack of 
connection between clinical provision and management.  
 
Whilst current philosophy adopted by Indonesian hospital pharmacists was to 
‘achieve definite outcomes and improve a patient’s quality of life’, the clinical-
specialist-centred model looked promising to actualise hospital pharmacists’ 
stated goals. Additionally, given the described avoidance of, and frustration 
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with managerial responsibilities, exacerbated by poor financial reward, it may 
be that there will be pharmacist shortages in the future. 
 
The study showed that pharmacists with patient-oriented care roles were 
focused on the pharmacists’ perspectives (as opposed to the patients). 
Different interpretation of what 'patient-oriented care' means has also been 
reported previously. Mil et al. compared various definitions of pharmaceutical 
care in the literature and outlined the limitations of a patient’s role in the 
definition of patient-oriented care (14). In addition, definition of 'outcome' has 
also caused confusion (14). These authors recommended for each country, 
there needed to be incorporation of the culture, language, and healthcare 
practice when defining the term (14). This is a major challenge when a 
country adopts a philosophical definition from a different context, which is 
reflected in the national standard for health care. In the Indonesian context, 
pharmaceutical care is an integral part of hospital care to provide clinical 
services, and efficacious and affordable pharmaceuticals (13). However, the 
definition emphasizes processes in pharmaceutical services but without a 
clear definition of ‘definite health outcomes’ and ‘a patient’s quality of life’. As 
a result, practice models may vary significantly in hospitals across Indonesia. 
 
Although it seems that current definition of pharmaceutical care is adequate 
to describe current practice, the study participants reported the impact of 
external and internal forces on their roles in hospital pharmacy. Some 
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external factors, such as changes in health insurance system and 
regulations, threatened hospital pharmacists’ ability to provide cost-effective 
and accessible medicines. For example, the current insurance system used a 
case-mix approach, which means a hospital is funded according to defined 
disease categories, and hospital is expected to deliver optimal medication 
management with finite funds. Another example, written in the hospital 
accreditation standard, is that pharmacists are expected to manage 
medication therapy to conform to relevant laws and regulations (15), even if 
resources are limited. 
  
Internal resources also influenced hospital pharmacists’ ability to provide 
services. Many supportive management tools assisted pharmacists in their 
managerial roles. For example, use of a computerised system reduced errors 
(16, 17), and improved service speed (16). However, the implementation of 
advanced technology was thought to increase costs (18). It may be very 
challenging to implement new technology across low-middle income 
countries such as Indonesia, particularly in rural areas. Therefore, a re-
definition of pharmaceutical care to match more with Indonesian context may 
be valuable for the profession and patients. 
 
In the next chapter, the challenges in hospital pharmacy management were 
explored to provide profound understanding of the Indonesian hospital 
pharmacists’ concerns over their managerial roles. 
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4. Concerns in Indonesian Hospital Pharmacy Management 
 
 
Background: Management is an essential factor to strengthening health 
systems and improving health in low-middle income countries, particularly in 
relatively poorly resourced setting. In Indonesia, pharmacy is an integral part 
of a hospital setting of care, and provision of good management practice may 
be challenging. 
Objective: To explore Indonesian hospital pharmacists’ experiences and 
concerns in the management of hospital pharmacy. 
Methods: Qualitative research was undertaken involving semi-structured 
interviews. Constructivist grounded theory was adopted to generate key 
themes. 
Results: A total of 31 pharmacists were interviewed. Planning of hospital 
pharmacy was challenging, and the managerial activity was sometimes 
absent. Most participants reported their main focus in pharmacy 
management was operational issues, such as human resource and service 
management issues. To work in multidisciplinary areas of health care was 
challenging and lacking in support. Most participants proposed health-system 
improvements and leadership to manage issues in hospital pharmacy 
management. 
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Conclusion: Indonesian hospital pharmacists worked in constant tensions 
between finite resources and increasing demands. However, current 
pharmacy management activities focused on operational issues, with a lack 
of strategic planning. Much room for improvements in health-system and 
leadership is clear. Further study about the gaps between planning and 
operation may yield better understanding of this issue. 
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4.1. Introduction 
The Republic of Indonesia (Indonesia) is an archipelago country located in 
South East Asia, comprising 34 provinces with more than 17,000 islands (Fig 
4.1) (1). Indonesia is spread over 1.9 million square kilometers and in 2015 
has a population of more than 252 million (2, 3).  Indonesia also includes 
people from a wide variety ethnic groups, and more than 700 linguistic 
backgrounds (3). Indonesia is considered by the World Bank to be a lower 
middle income country (4). 
 
Figure 4.1. Map of Indonesia 
  
WHO states that management is an essential factor to scale up service 
delivery to strengthening health systems and improving population health in 
low-middle income countries (5). In this context, management is defined as a 
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process which brings together resources and unites them in such a way that, 
collectively, they achieve goals or objectives in the most efficient manner 
possible (6). In classical management theory proposed by Fayol, there are 
five management functions that all managers perform: plan, organise, 
command, coordinate, and control (7). Managers in the hospital sector are 
key health service managers especially in low income countries (8). In 
Indonesia, pharmacy is an integral part of a hospital setting of care, and all 
pharmaceutical products and services are usually managed by a sole 
pharmacy department within the hospital (9). However, it is common for 
many hospital pharmacists to overlook and shun rather than value 
management practice, because it is perceived as unaligned with and contrary 
to pharmacists’ clinical roles in community health (10). Furthermore, with 
constant changes in the health industry and the relatively poor resource for 
the health setting in low income countries, pharmacy managers have 
constant challenges to provide good management practice.  
 
A number of studies have investigated management perspectives in the 
setting of hospital pharmacy practice. Bond et al, investigated the 
associations among hospital characteristics, staffing levels, and mortality 
rates in the US (11). Harrison explored the extent and quality of strategic 
planning in institutional pharmacies, and the potential influences from 
pharmacy directors (12). Sloan et al, examined the use of cost-effectiveness 
analyses in hospital formulary decision making processes (13). Although 
much study has explored and proposed the benefits of human resources, 
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financial and strategic planning and management, very little is known about 
issues in managing hospital pharmacy in developing countries. The previous 
chapter explored the Indonesian hospital pharmacists’ perceptions of roles, 
and revealed that managerial roles were often ignored. Therefore, this 
chapter focuses on participants’ experiences in managing hospital pharmacy. 
 
4.2. Objective 
The aim of this study was to explore Indonesian hospital pharmacists’ 
experiences and concerns in the management of hospital pharmacy. 
 
4.3. Methods 
The methods for Stage 2 of the study are outlined in Chapter 3. 
 
4.4. Results 
The number of participants of Stage 2, and their characteristics are outlined 
in Chapter 3 (Table 3.2). In this chapter, four key themes relating to the focus 
of the topic were identified: “issues in planning”, “issues in operations 
management”, “organisational culture”, and “proposed solutions” are 
described below. Each of these themes and subthemes is discussed in detail 
below with relevant quotes from participants. 
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4.4.1. Issues in planning 
Participants reported their opinions about problems related to planning 
activities in the hospital pharmacy sector. The nature and effect of the 
external environment was reported. The degree of planning deficiency was 
expressed. The impact of an absence of planning was also reported. 
 
4.4.3.3. Threats and opportunities for hospital pharmacy 
Participants acknowledged the significant the impact of the external 
environment on hospital pharmacy planning and activities. Fluctuating trends 
in the pattern of diseases and treatment was common: 
“Patients’ condition in wards is fluctuating. Sometimes we’ve got 
emergency situation, and in that case, nurses will request so many 
things. We need to be ready.” (P16) 
 
Increasing demands of providing quality care for patients was also reported: 
“We’re also faced with constant change in patient awareness; in the 
past patients were not so informed in medicine, but now people are 
smart so we need to keep upgrading our staff, train them non-stop.” 
(P15) 
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Interestingly, most participants from outside of Java reported geographical 
constraints in managing access to pharmaceuticals: 
“Concerning logistics, since we’re in a marginal area, the common 
problem is running out of certain drugs. Recently we ran out of 
epinephrine, which is a big problem since it’s a life-saving drug.” (P14) 
 
4.4.1.2. The magnitude of planning issues 
Ineffective planning at the departmental level was reported as impacting on 
hospital pharmacy practice. Inconsistent planning behaviour at the hospital 
level especially affected inventory management in hospital pharmacy and 
had an impact on accessto  medicines needed in a timely manner: 
“The problem is flexible cycle for deadlines. They may ask us to finish 
the plan tomorrow. Sometimes I have to develop their understanding 
that we should have a rigid schedule. Sometimes we can’t predict it. 
Unexpectedly I can be asked to submit my budget tomorrow. Do they 
think it’s easy to plan for drug budget?” (P30) 
 
Lack of thoughtful planning at the national level was also reported by many 
participants, reflected in the inadequacy of a national formulary, poor 
monitoring system, and insufficient pharmacy education: 
“We are supposed to have 100% compliance rate with our hospital 
formulary. But, the results are not 100%, especially for inpatient 
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because there are only around 900 items in national formulary for 
publicly funded patients. This hospital is a type A hospital, that means 
we are handling complex diseases, but not all medicines are listed in 
the national formulary.” (P5) 
 
“My opinion is (laughs) that the government itself has questionable 
integrity. It’s not consistent; writing strict regulations but not doing any 
monitoring.” (P24) 
 
“[My daily work] gets me to learn management, so I think it’s a shame I 
didn’t get this kind of subject when I was in college.” (P24) 
 
4.4.1.3. Lack of strategic planning 
Pharmacists also reported their concerns on the absence of strategic 
planning in this sector. The lack of a strategic approach blurred the vision of 
the pharmacy department, and sometimes distorted its focus: 
“When we have decided our goal that we want to be a holistic cancer 
hospital. Then we can decide what kind of doctors we should recruit, 
what kind of drugs we should supply, how qualified our nurses should 
be, how we promote our hospital, and what ancillary services we need 
… But if we don’t have it, we don’t know where we are going. It’s not as 
bad as not knowing what to do when I come to work today, but at least 
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we need a clear plan of what we do for the future … when we are 
working on accreditation, sometimes there’s a doctor came up with a 
potential business plan. Then pharmacy had to work on it too, which is, 
I don’t see any relevance with accreditation or this hospital 
characteristics. So it’s a distraction because I don’t think it’s our goal.” 
(P8) 
 
Without effective resource planning, basic services in hospital pharmacy 
were impeded: 
“The government has not even complied with their regulation. Have 
they prepared budget for [hiring more pharmacists]? [I’m not sure] 
because I can’t even have ideal pharmacy room at the moment … 
Although [clinical pharmacy, therapeutic drug monitoring, etc.] are listed 
in the standards of hospital pharmacy practice, I do not wish to do 
grandiose things like them (at the moment).” (P17) 
 
Very often pharmacists were not involved in decision-making processes, 
which resulted in more challenges in medication and service management: 
“I think the major constraint is the hospital executives. I told you before 
that this is a non-profit hospital so that we don’t know anything about 
money. When I plan to purchase medicines this much, they can reject 
that without giving me awareness, they don’t tell me. This hospital is 
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owned by nuns, so they put a nun to handle purchasing. The nun is also 
a pharmacist, so it looks like I have two superintendents. I want to go 
left, but the one who has money wants to go right. So far I don’t feel it’s 
burdensome, but I feel that my idea can’t be innovative.” (P10) 
 
4.4.2. Issues in operations management 
Managing operational activities in pharmacy was perceived as problematic by 
all participants. Challenges in people management were emphasized by 
many participants. Problems related to service management were also 
described. 
 
4.4.3.3. Human resource management issues 
People management was a prominent challenge reported by participants in 
hospital pharmacy management. A poor financial remuneration structure 
could not stimulate ownership and participation by hospital pharmacy staff: 
“My staff also don’t think the annual increase is significant. The 
manager involved me when calculating salary increase; we have a 
grading system to justify the increase: A, B, C, and D. Staff with A’s will 
get the highest increase, although not too much; and those with D’s 
aren’t getting an increase. In average, pharmacy staff get an increase of 
IDR 100-200 thousand (around USD7.5 to USD15 per month); and 
they’re not impressed with this.” (P14) 
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In a concerning admission, participants also reported poor safety protection 
at work: 
“In medication safety [in my ward], we have one isolation room; which is 
the problem. In tropical infection, there are so many illnesses, for 
instance diphtheria, pneumonia, MRSA, so all are tropical infection and 
needs to be admitted to isolation room. But since we only have 1 room, 
if there are more than 1 patient that are suffering from those diseases, 
they’ll get mixed up with other patients who are only admitted for 
dengue fever or diarrhea. It implies to us, to nurses.” (P1) 
 
Another interesting concern reported by a participant was the feminization of 
pharmacy department staff profile, which sometimes led to unexpected 
absence at work due to family issues or health status: 
“From the pharmacy’s side, we’ve had many new staff, so I have to 
teach them everything; because most of these new recruits are fresh 
graduates with zero working experience. It’s difficult to find experienced 
human resources in (this city) so we just take what’s available, we can’t 
be too selective; considering we’re in need of manpower. Also, 
generally people with experience are married, with a child, or expecting 
a child; and most of them are women. It’s difficult to find male 
applicants, especially in (this city) … Like I mentioned earlier, even if we 
can recruit 3 people, five could get pregnant, and we’re back where we 
started. I haven’t got pregnant yet (laughs) but I know how it’s like. 
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During the first trimester they would get ill all the time, some even get 
admitted. Just recently we had 3 staff admitted during pregnancy. So 
our work hasn’t been effective.” (P14) 
 
4.4.3.3. Service management issues 
Another considerable challenge reported by participants is managing service. 
Participants described being frustrated in attempting to deliver timely 
pharmacy services because participants reported that the health industry was 
very dynamic, and there were finite resources available: 
“The one problem I still can’t solve is how to reduce waiting time, 
because we’re still stuck … Even if we get more people we’d always be 
in shortage of staff because the number of patients keep increasing, 
staff get sick all the time, and the pneumatic tube keeps failing. Nothing 
can be done, we’re stuck.” (P14) 
 
The application of computerised information systems was commonly reported 
by participants hoping to assist in delivering timely services, but these 
systems were also reported as being the source of other problems: 
“We have insufficient Hospital Information System (HIS) here to 
increase our working speed. The system requires so much time to load 
[databases], the stock level are not update, too many processes [to do 
one task]. We need a long time just to work on one script.” (P4) 
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4.4.3. Organisational culture 
The study respondents expressed emotional responses when asked about 
the challenges of working in hospital. Difficulties in working with other health 
professionals were also highlighted. A lack of appreciation from other people 
was also reported. Participants also described their attitudes towards work 
culture. 
 
4.4.3.1. Working in multidisciplinary areas of health care 
Most participants reported frustrations when working in the hospital 
environment. It was common to separate functions between clinical and 
inventory practice, which in turn created a segmented and blaming culture: 
“There’s no aligned mindset between [inventory] management and 
[clinical] services … Sometimes we think that, “Oh this is her work; that 
is his responsibility.”” (P2) 
 
Working with medical staff colleagues was also reported to be very 
challenging because participants perceived that doctors were not willing to 
work with pharmacists as a team: 
“We are actually supposed to circulate new drug’s proposal form to 
medical staff, but because it usually took us a long time [to get it back], 
we finally reviewed our 2014 data, and we created a list of medicines 
where the doctors only need to tick on each medicine they want. Even 
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though we have made it easy like that, we still have no return. I think 
that’s because contract doctors here do not have any sense of 
belonging and they don’t want to comply with the formulary.” (P3) 
 
Although a Drug and Therapeutics Committee was established in the 
hospital, participants expressed their frustration because doctors were 
reluctant to be involved in this role: 
“Nobody came to DTC meeting. Although there are representative from 
whatever, representatives from this department, they didn’t come as if 
they tried to wash their hands of the dirt, and then said, “That’s up to 
you, pharmacy, whether you want to supply it or not.” That’s the ending, 
it’s really stressful. They didn’t feel it was their decision.” (P10) 
 
When improvement programs were implemented by hospital executives, it 
was common to have resistant staff who were unwilling to leave their 'comfort 
zone': 
“There were many changes with hospital executives etc. Perhaps for 
people who were resistant to change, they didn’t feel comfortable with 
it. With new regulations, perhaps not everyone was willing to change, 
especially when there were many changes at a same time.” (P8) 
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4.4.3.2. Insufficient support 
In general, participants perceived that pharmacists received a lack of 
recognition and appreciation in the hospital setting. One participant shared 
their bitterness when conversing with a pharmacy owner who preferred to 
recruit pharmacist assistants rather than pharmacists: 
“I’ve conferred with business people, they told me it’s better for them to 
have more pharmacy technicians than to have more pharmacists. If 
we’re talking about drugstores, it’s best to have more assistant 
pharmacy technicians than more pharmacists. That’s Indonesia for 
you.” (P24) 
 
It was also challenging to motivate pharmacy staff to work to at their best 
because there was not enough appreciation of their work: 
“I demand [my staff] to work to the best of their abilities, but on the other 
hand they are not being properly appreciated for their work. 
Appreciation either in the form of money or intangible ones like 
gatherings and the likes.” (P24) 
 
Continuing learning support was also acknowledged by participants as an 
importance aspect of professional development but this was still inadequately 
provided: 
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“Our position is not like doctors. We don’t receive many support for 
training … hospital has seen pharmacy good enough and has complied 
with standards, so what does pharmacy want to learn?” (P8) 
 
Interestingly, in a public hospital context, non-civil servant respondents 
reported employment discrimination in terms of appreciation, compared to 
those who were civil servant workers: 
“We have similar entitlement [among all pharmacists], but with different 
amount (between civil servants and [hospital] staff) … (Laughs and a bit 
hesitate to answer) There’s a big gap, quite big, almost 1:2-3 times.” 
(P16) 
 
4.4.3.3. Pharmacists’ responses 
As a result of this level of frustration in hospital pharmacy, respondents had 
various responses, most of them became pessimistic. Some participants 
believed there was a lack of relevance of written regulation to practice: 
“For accreditation, even if we do not counsel the patients, we’ll ask their 
signatures. So patients consented that they have been counselled, but 
it’s actually not happening. Is it wrong? It is. But that’s what we need to 
do for accreditation, we must have proper documentation.” (P21) 
Some also believed that existing system was poor in monitoring, which led to 
abundant paperwork, rather than direct implementation: 
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“Now, I don’t always report this [expired drugs'] list, I just keep it as my 
record. When the management asks for it I give it to them. Now once 
they see the record suddenly all the regulations come out of nowhere, 
like they make up all these rules in a day. Basically my unit has to pay 
for all the expired drugs ... If I report [expired drugs], that would be like 
I’m surrendering myself to the police. When they do inspections I never 
tell them anything except what they ask. I’m being bad because I’m 
tired of them.” (P11) 
 
Moreover, some even seemed to lose hope about the professional identity as 
pharmacists: 
“We know in Indonesia not all hospitals are accredited, sometimes near 
accreditation periods everyone is panicking to make deadlines … When 
you want instant results, you copy-paste from others. This is 
problematic. It makes our jobs in the operational sections difficult, and it 
also makes us lose hope toward the ideals.” (P24) 
 
4.4.4. Proposed solutions 
Although managing hospital pharmacy was regarded as problematic, many 
participants proposed potential solutions for their problems. Promotion of 
leadership was a key suggestion and governmental support through 
regulation was also expected. 
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4.4.4.1. Leadership in hospital pharmacy 
Good hospital leaders were identified as a key solution by participants. They 
believed that a good leader ought to establish and maintain consistency in 
actions: 
“We need a strong motivation because what’s important [is not the start 
but] the consistency.” (P22) 
 
Participants also expected much support from hospital leaders to help them 
work optimally: 
“No matter how good the pharmacy is, no matter how qualified the 
pharmacists are, without executives’ support we can do nothing.” (P7) 
 
A participant even reported the need for replacement of hospital executives 
who were unsuited to the strategic role required in this setting: 
“Even if all those hopes are fulfilled, I’m still not sure if things will get 
better; because first of all I think without reconstructing the board of 
directors, the people upstairs, without refreshing the management, 
things will stay the same. They will solve problems the same way 
they’re doing it now.” (P11) 
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4.4.4.2. Regulations to support practice 
There was much dissatisfaction with current pharmaceutical policy, and 
participants recommended the need for improvement in the relevant 
regulations. One important aspect in the current regulatory framework was 
the expectation participants had that the government should strictly regulate 
medicine prices and distribution in the market: 
“I see that our main problem is with government’s regulation of drugs in 
market … Without that, we –practitioners– won’t be empowered.” (P7) 
 
4.5. Discussion 
The findings of this study highlight current issues in the management of 
hospital pharmacy in Indonesia. Figure 4.2 shows current management 
functions and influential factors in Indonesian hospital pharmacy derived from 
the participants in this study. Although the results suggest that hospital 
pharmacists expressed their concerns over issues in planning and 
operational management, they identified that their current management 
functions focused heavily on operational issues. The results also indicate a 
gap between planning and operational management roles, because 
monitoring and feedback were reported to be minimal or absent. These 
concerns were a source of frustration for the study participant and were 
thought to limit improvements in the health system. 
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Figure 4.2. Relationships among factors influencing hospital pharmacy management in Indonesia 
          Functions are minimal to absent 
         Functions are present  
4.5.1. Issues in planning 
The results of this study suggest that external factors –such as changes in 
national health system, disease trends, patients’ demographic 
characteristics, or surrounding geographical factors– were inevitable and 
affected their institutions. These factors could threaten hospital services, but 
also could provide more opportunities for development. Yet, many 
participants expressed concern that the organisations failed to adapt to the 
changing environments. There may be opportunities missed if there is a 
failure to plan strategically. Literature suggests that strategic planning is the 
most crucial function in management because it maximises an organisation’s 
future success (14). Planning is useful in the process of strategy 
development and implementation (15). Therefore, failure to plan strategically 
could mean that hospital pharmacy would be limited to deal only with daily 
operational problems, without opportunity to solve underlying problems.  
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Few respondents reported their concerns over the absence of management 
and planning skills and its implications on service provision. This may 
indicate that pharmacists were not commonly involved in planning activities, 
even the fundamental responsibility of inventory planning. This result also 
mirrors a lack of knowledge and training in pharmacy management among 
hospital pharmacists. Harrison suggested that with little knowledge of 
strategic planning, pharmacy directors did not implement, or partially 
implemented strategic planning in hospitals (12). However, in this study, lack 
of awareness in the importance of managerial skills was shown not only by 
the Directors of Pharmacy, but by the majority of participants. This is not 
surprising given that the Indonesian pharmacy curriculum is heavily biased 
towards pharmaceutics, pharmacognosy, and laboratory work (16). Although 
most universities have offered concentrated curriculum into pharmacy 
practice and scientific aspects of pharmacy, pharmacy management is a very 
small part (if at all) in the pharmacy undergraduate curriculum (17). This is 
consistent with the results of this study, and reflects not only local but also 
potentially a national issue. Lack of awareness at national level may be 
explained by a perception that strategic planning has lack of impact on 
service provision (12). Little has been reported about the utilisation of 
strategic planning in different types of hospitals within Indonesia. Therefore, 
exploration of the topic could merit further study. 
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4.5.2. Issues in operation management 
The present results reveal that there were tensions between the finite health 
resources and increased demands for pharmacy services. The most 
challenging aspect in operational management was human resource 
management. The results propose that pharmacy staff were not happy with 
the poor appreciation of their roles and contribution in hospitals, and they had 
become demotivated and disengaged. Consequently, managers faced more 
difficulty with managing operations. This result was not unexpected because 
recognition or support was found as one significant predictor of job 
satisfaction (18, 19). Moreover, job satisfaction has a major influence on 
workplace performance. Therefore, factors contributing to job satisfaction 
should be fostered to maximise job performance. Nevertheless, little is known 
about work satisfaction in Indonesian hospital pharmacy and its related 
factors. Research on such topic may offer benefits for improvements in 
hospital pharmacy service. 
 
Another interesting finding from this study is that a participant felt that the 
feminisation of hospital pharmacy was associated with workplace shortages. 
It is a consistent finding in pharmacy, as for some other health professions, 
that women are highly represented in the workforce (20). The feminisation, 
however, challenges hospital pharmacy managers to manage service 
provision, particularly during essential staff profile changes during staff 
pregnancy and childbearing commitments. One respondent even 
emphasized that feminization is a constant condition in pharmacy, which 
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would keep challenging hospital pharmacy and needed to be better managed 
with appropriate workforce planning in hospital pharmacy. 
 
Computerised systems were also commonly reported to be expected to 
simplify and support timely service provision. This result is not unexpected as 
many studies have focused on the benefits of computerised systems, ranging 
from electronic prescription (21, 22) to utilization of barcode systems for 
inventory control (23). In brief, hospital information systems may contribute to 
high-quality, and efficient patient-centred care (24). However, some hospital 
information systems were reported to pose undesirable problems and 
elongated service time. This could be explained due to a mismatch between 
the ideal design and practice reality.  
 
Heeks highlighted the subjectivity of an information system, with 
consideration of ‘institutional objectives and values, activities, human skills, 
organisational structure, and technical infrastructure’ (25). Further research in 
this area could yield better understanding, and facilitate implementation of 
future electronic systems. 
 
4.5.3. Organisational culture 
The findings of this study indicate that Indonesian hospitals were dominated 
by medical staff. Doctors were reported by hospital pharmacist participants 
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as the most 'difficult' professionals to work with in a team. Chang et al, also 
found the similar results in a Taiwan hospital (26). Doctors were generally the 
decision-makers and had higher income than other professions in the 
hospitals, which created a sense of difference between doctors and nurses 
(26). Although salary disparities between Indonesian doctors and 
pharmacists were not a focus for this study, similar reasons may be 
applicable (27). 
 
Despite the role expansion of pharmacists in many countries, the profession 
is still not well recognised in Indonesia. The respondents in this study 
explained that a pharmacy owner preferred to hire support staff rather than 
pharmacists, or to engage nurses in managing medication imprest stock 
rather than stationing pharmacists in wards. This suggested that hospital 
pharmacists were not recognised as having a specific role, and were lacking 
a niche because they could be replaced by other health professionals. 
Indonesian pharmacists work not only in healthcare settings, but also in 
pharmaceutical industries and in the distribution facilities (28). To prepare 
pharmacy students for various workplaces, Indonesian undergraduate 
pharmacy curricula offer a diverse range of courses (17). The education and 
training of pharmacists for future roles, including those within hospital 
management is fundamental and to the development of the profession in this 
area (29). 
 
 118  
4.5.4. Proposed solutions 
This study found that respondents had high expectations for effective 
leadership and regulation. This finding suggested that current hospital 
settings in Indonesia widely practice transactional leadership. Transactional 
leadership occurs when leader, possessing clear authority, motivates by 
reward or punishment (30). This is not surprising because of the hierarchical 
nature of professional relationships in healthcare settings (30). 
 
However, the effectiveness of transactional leadership in a changing 
environment such as the healthcare sector is questionable. Firstly, 
transactional leadership may curb leadership potential in each pharmacist 
because changes must be initiated from higher positions. In the healthcare 
industry where people are highly skilled and are used to working in a 
particular way, staff may tend to be more resistant to change (30). Secondly, 
an emphasis on regulation may retain staff ownership and commitment to 
work. A study conducted in Taiwan also suggested that laying too much 
emphasis on rules might cause the decline of subordinates’ identification 
within the organisation (31). Some literature suggested transformational 
leadership which occurs when a leader inspires people to follow them 
through vision, passion, and enthusiasm (30). Another study suggested a 
combination between transactional and transformational leadership may be 
applied in different contexts (31). Research which explores effective 
leadership styles in Indonesian hospital context may provide more 
understanding. 
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5. The Future of Hospital Pharmacy in Indonesia 
 
 
Background: In Indonesia, medicines accounted for 12–38% of hospitals’ 
expenses and the environment has been in constant changes. At a global 
level, a consensus of the future of hospital pharmacy has been published. 
However, little is known about the potential future development and 
challenges in developing countries. 
Objective: To explore views and perceptions of Indonesian hospital 
pharmacists related to the professions future direction and vision for hospital 
pharmacy practice. 
Methods: Qualitative research was undertaken involving semi-structured 
interviews. Constructivist grounded theory was adopted to generate key 
themes. 
Results: A total of 31 pharmacists were interviewed. The majority of 
participants expected more active involvement in medication use 
management, where clinical and managerial roles were separated. In 
contrast, some participants endorsed the importance of pharmacy 
management. Characteristics of supportive regulations and systems were 
reported, and many reflected on other countries’ experiences. 
Transformational leadership style in hospital pharmacy was also deemed 
appropriate for current situation. 
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Conclusion: Indonesian hospital pharmacists wished for a greater recognition 
of and contribution to the profession. Changes in health system and strong 
leadership were highly expected. However, with different opinions about 
hospital pharmacists’ professional identity, the future of hospital pharmacy in 
Indonesia still faces potential challenges. 
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5.1. Introduction 
Pharmacy has a unique position in the hospital sector. Hospital pharmacists 
manage drug distribution systems and conduct a wide range of clinical 
activities (1). In addition to managing systems, hospital pharmacists are 
responsible for resource management, financial control, and the safe and 
appropriate use of medicines in the hospital (2). In Indonesia, medicines 
accounted for between 12 – 38% of hospitals expenses in 2012 (3) and 
hospital pharmacy was expected to be actively involved in inventory 
management and medication use (4). 
 
In brief, hospital pharmacy is a complex intersection between quality and cost 
of care. There is involvement of management and service delivery, balancing 
the expectations of hospital managers and patients, and all of these factors 
underpin the several different expectations held of hospital pharmacists.  
 
Changes in health care environments have led to hospital pharmacy quickly 
adapting to health system needs and drivers. Hospital pharmacy has to 
maintain access and safety of medication use (5). However, development of 
hospital pharmacy may be constrained by a number of factors. Matsoso 
outlined potential future challenges for hospital pharmacy (Table 5.1) (6). 
Although much evidence about benefits from several expanded roles of 
pharmacists has been reported at the international level, the impact of these 
data on decision-makers is unclear (6). Inequity in access to supports for 
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hospital pharmacy services such as information and technology, workforce 
and finance, education and clinical pharmacy activities have been reported to 
hinder hospital pharmacy development (7). 
 
Table 5.1. Future challenges for hospital pharmacy 
Demographic challenges 
   Uneven distribution of pharmacists (practice area, geographic, sex) 
   Task shifting in pharmacy profession 
   Limited resources at hospital pharmacy 
Information management 
   Development initiatives are narrowly driven 
   Poor communication between different players to achieve definite patient outcomes 
   Lack of coherence of approaches, especially at the national level 
  
An international consensus over the future vision of hospital pharmacy 
practice has been achieved between hospital pharmacy leaders. The 
consensus is known as the “FIP Basel Statements” (8). These are based on 
statements related to the medicine management cycle, medicine use and 
monitoring, organisation of hospital pharmacy, and personnel management 
(8). International and national guidelines have been published to provide a 
basis for evaluation and goal setting in hospital pharmacy (2). However, little 
is known about the actual vision and ideal future of hospital pharmacy in the 
context of the Indonesian health care system or in other developing 
countries. 
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5.2. Objective 
The aim of this study was to explore views and perceptions of Indonesian 
hospital pharmacists, specifically about the future direction of the profession 
and vision for hospital pharmacy practice. 
 
5.3. Methods 
The methods for Stage 2 of the study are outlined in Chapter 3. 
 
5.4. Results 
The number of participants of Stage 2, and their characteristics are outlined 
in Table 3.2. In this chapter, two key themes relating to the future of hospital 
pharmacy were identified: ‘future directions’ and ‘external environment’ are 
described below. The first theme was categorised into four subthemes: 
personal qualities, contribution, roles, and recognition. The latter was 
categorised into three subthemes: regulation, system, and leadership. Each 
of the themes and sub themes is detailed below with relevant quotes from 
participants. 
 
5.4.1. Future directions 
Hospital pharmacists reported expectations for the future of their profession. 
They outlined some strengths a hospital pharmacist should have. All 
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participants expressed their wish to have more active involvement in 
medication use and management regardless of their hospital practice 
settings. Furthermore, ideas about possible future roles of hospital 
pharmacists were described. Despite existing challenges to the profession, 
hospital pharmacists demonstrated their eagerness to make significant 
contribution to health care services. 
 
5.4.1.1. Desirable pharmacists’ qualities 
Many participants reflected on the intrinsic qualities a hospital pharmacist 
ought to have. Profession zeal was deemed critical for hospital pharmacists 
to motivate themselves in an inter-professional and patient-centred practice 
environment: 
“We need zealous pharmacists who keep increasing their competencies 
so they can collaborate with other healthcare professionals and can 
contribute positively in patients’ therapy.” (P20) 
 
When responding about working in such environment, hospital pharmacists 
expected themselves to do it with compassion; and such attitude was only 
possible if they worked with passion: 
“[A hospital pharmacist needs to be] care with everything, to [work] 
environment, to patients. Concomitantly, this is not a cliché and not a 
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philosophy class, but it is an important factor … People should work 
according to their passions.” (P23) 
Additionally, standardised competencies ratified by a professional association 
were needed; and in some areas, specialisation was preferred: 
“I also wish we could have a pharmacy council … I hope for a council. 
So we can have certification from council, not by professional 
association. And then standard for graduates. For surgeons, their 
standards are determined by their council. So they will be examined 
before they are graduated.” (P21) 
 
“Ideally, if pharmacists want to work in hospital pharmacy, they should 
intensify their comprehension to a specialised level.” (P20) 
 
5.4.1.2. Active involvement in medication management 
All participants expressed their wishes to work in close proximity with 
patients. Despite the fact that hospital pharmacists were not always present 
at all points in medication use and management, the participants emphasized 
their desire to be recognised as part of the healthcare team: 
“I want pharmacists to not become a separate entity with medicines. 
Likewise doctors with ECG, CT scan, MRI results. Nobody is able to 
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interpret the results except doctors, aren’t they? So I want where there 
are drugs, there are pharmacists.” (P19) 
 
As a result, hospital pharmacists wished to be physically present in wards, 
particularly in critical areas, such as intensive care and emergency 
department: 
“Pharmacists have to be in ED, ICU, and operating theatre.” (P4) 
 
Interestingly, some respondents were aware of their collaborative roles, 
despite making a ‘one-man-show’ in medication management and use: 
“I also don’t want pharmacists to be arrogant and ostentatious, but at 
least they can have an effect at the right moment. So when doctors fail 
to remember, they should remind them.” (P10) 
 
5.4.1.3. Separation between clinical and managerial roles 
When the term ‘management’ was asked to participants, most of them 
regarded management as ‘supply-chain management’. Contradictory views 
about hospital pharmacists’ roles in the future were reported by participants. 
Although pharmacists realised their inseparable function in medication 
management and use, majority preferred to focus on clinical roles; and 
delegating the managerial roles to another person: 
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“I would rather have someone else hold the managerial position so I 
can focus on the clinical pharmacy unit.” (P11) 
Only a few participants were willing to delegate clinical roles to other 
pharmacists and take managerial responsibility, particularly in inventory 
management: 
“How good it is to have someone managing medication use, like a 
clinical pharmacist who has data of which patients receive which drugs. 
So he can cooperate with me, I know the trend or adjustment in current 
therapy. And I can control the stock level.” (P22) 
 
The notion of being responsible for hospital pharmacy management was 
deserted, and only very few participants emphasized the importance of a 
good pharmacy management to support hospital pharmacists’ clinical roles: 
“Management of tens of percentage of hospital money is here. If this is 
not managed well, if drugs are expired, unused, wasted; if we have 
unmanaged return drugs, I can say until we have good management 
practice, then we can have good clinical pharmacy practice. If we want 
to divide the roles, that’s fine, but we need to improve the management 
first.” (P7) 
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5.4.1.4. Greater recognition 
All participants wished for acknowledgement from other people in the 
hospital. Although in existing practice hospital pharmacists were involved 
mainly in inventory management, recognition from doctors to collaborate in 
medicine use was expected: 
“I want to improve collaboration with doctors, I hope we can do ward 
rounds together and they perceive us as partners (rather than 
submissive colleagues).” (P13) 
 
Furthermore, appreciation from management executives was also anticipated 
so that pharmacists could access more resources for their work: 
“I wish that hospital executives do not only demand us to do UDD or 
clinical pharmacy services in all wards, but they do not fulfill our staff 
needs.” (P16) 
 
The opportunity for higher positions was deemed as recognition for early 
career hospital pharmacists: 
“In that hospital, the director of pharmacy was reshuffled every two 
years. I was also surprised, at my age a pharmacist could be a director 
of pharmacy.” (P23) 
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Interestingly, a hospital might also wish to make more contribution in 
regional, national, or international level: 
“As a referral hospital, our target is to go international, and to contribute 
in regional level, at least in South East Asia.” (P31) 
 
5.4.2. External environment 
In this study, external environment was defined as the surrounding conditions 
in which hospital pharmacy or hospital pharmacist operates. Hence, the 
subtheme consisted of perceived ideal regulations, system, and leadership. 
 
5.4.2.1. Strict regulations 
All respondents highlighted an urgency to uphold regulations. Although 
national standards and policies have been authorised, a lack of 
implementation by hospital pharmacists was reported: 
“There’s policy, there’s legislation, there’s regulation, but no evaluation; 
so? It’s the same thing all over again. Thus, actually this small 
organisation of mine represents a larger entity: this nation. That’s my 
opinion. If the government would come down and firmly uphold the 
regulation, no one would dare look for loopholes.” (P24) 
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At a local level, hospital formulary was considered as the underpinning guide 
to medication use and management, thus conformity to formulary was 
essential in pharmacy management: 
“What is it in a good pharmacy? There’s conformity to hospital formulary 
… Once the pharmacy management is performed neatly, we have clear 
drug selection criteria, efficient, proper drug distribution; that means we 
are efficient.” (P7) 
 
Organisational management of staff with close monitoring was also 
considered important in maintaining pharmacy integrity and transparency: 
“Purchasing isn’t under pharmacy, although it’s run by a pharmacy 
technician. It’s a different department … This is necessary to prevent 
pharmacy staffs from cutting deals with distributors; so we have a whole 
division supervising us.” (P14) 
 
5.4.2.2. Efficient system 
All participants reported their wishes for an ideal system. Having sufficient 
facilities and equipment, and hospital-specific workflow were identified as 
essential for service provision: 
“Different facilities have different infrastructures and instruments, so 
each should have a unique flow of service provisions.” (P24) 
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Computerised hospital information systems were expected to be throughout 
the whole hospital to support pharmacy management and improve 
medication safety: 
“If we can have automatic update [in online system], if every change in 
formulary affects our master data, it will reduce error.” (P22) 
 
Expectations to be equivalent to other countries were commonly reported by 
participants. For example, a system was considered ideal or efficient if it 
facilitated data management and simplified inventory management: 
“From what I have seen in big hospitals in Malaysia, they have 
centralised pharmacy. They don’t have a satellite in each unit. 
Technicians go to wards every morning, they will record medication 
orders, match them with medical records, and they will return back to 
pharmacy to dispense the orders. I think that’s ideal.” (P21) 
 
5.4.2.3. Strong leadership 
Many emphasized their wishes for powerful leaders. Leaders were 
recognised as mediators who bridged different parties and views, and were 
key persons in a hospital: 
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“It is imperative for a facility to have a leader that joins hands with the 
staff, so that departments aren’t partitioned into A block, B block, C 
block, like what I feel we’re having here.” (P24) 
 
Leaders were also characterised by their ability to develop and convey vision: 
“They need to refresh the management, bring in competent individuals 
or those with a vision.” (P11) 
 
Moreover, leaders were also expected to encourage and guide their 
subordinates, instead of only setting targets: 
“For me the most important factor is to have a leader who doesn’t 
dictate you, give you target to meet; but one who motivates you.” (P15) 
 
5.5. Discussion 
The findings of this study may suggest that hospital pharmacists had low 
level of satisfaction with current practice. However, our results showed that 
they had aspirations for substantial improvements in their profession and 
environment. 
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5.5.1. Future directions 
Despite the expansion of pharmacists’ roles to be more clinical, hospital 
pharmacists were thought to also need zeal, compassion, and particular skill 
sets. Reforming zeal has been shown by pioneer pharmacists who made 
significant changes in pharmacy practice in the US (9). The same zeal was 
also sought in these discussions, so there might be improvements for the 
future of Indonesian hospital pharmacy practice.  
Hospital pharmacists have always worked closely with doctors, nurses, 
managers, other hospital staff, and patients (10). Collegiality is required to 
enable pharmacists to work with colleagues and across departments and 
disciplines. Furthermore, hospital-specific skills and in-depth knowledge were 
perceived as essential. 
 
Practice standards and competencies for Indonesian pharmacists have been 
ratified by the professional association (11). However, some felt that the 
standard was insufficient because it is aimed for all pharmacists who worked 
in all settings. This may be considered differently by those working in 
generalist or specialist roles  
 
It was clear that hospital pharmacists wished to be involved in every step of 
medication management and use. In many publications, pharmacists’ clinical 
roles were emphasized (12-15), and were influenced by the worldview of 
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hospital pharmacists (16, 17). Hospital pharmacists perceived themselves as 
medication experts who could take the responsibilities for patients’ 
medication. Given much research has reported positive outcome of 
pharmacists’ involvement in medication use, including reduced mortality rates 
(18) and cost-containment (19); it is not surprising that many respondents 
wished to be present physically at all points in the medication use cycle.  
 
The term of ‘management’ has been perceived negatively by many people in 
this study (20, 21). Management roles in hospital pharmacy were perceived 
to be limited to inventory management by most respondents. There was a 
common perception that pharmacy practice and management did not align 
(20). In the findings, the perception was common, especially among early 
career hospital pharmacists. 
 
Contrastingly, few pharmacists emphasized the importance of good 
management practice to support clinical pharmacy. These paradoxical ideas 
of ideal hospital pharmacists’ roles indicated internal future challenges for the 
future of Indonesian hospital pharmacy practice.  
 
That pharmacists expected recognition and appreciation from colleagues was 
clear (22, 23). The respondents to this study also expressed the wish to have 
partnership with doctors in medication management and use. Empowerment 
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from hospital executives, and opportunities for attaining higher positions was 
also desired. 
 
In a strategy to implement change management in a tertiary care hospital, 
education for hospital administration was provided to support the 
implementation of pharmaceutical care (24). Pharmacists seek job 
enrichment, recognition, or reward for their professional performance (25). 
 
5.5.2. External environment 
Hospital pharmacists expected compliance with professional standards. Most 
participants expressed their wish to have regular monitoring on the 
implementation of regulations. This result confirms previous studies about the 
value of research and audit mechanism in identification of gaps between 
standards and implementation, and in development strategy of hospital 
pharmacy (17, 26).  
 
A good formulary system was also deemed essential by our participants 
because when a hospital had a strong formulary system, clinical services 
could be supported. Many guidelines and standards highlighted the 
importance of formulary to guide medicines procurement and selection 
process (8), to ensure drug availability (4, 27, 28), to optimise limited 
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resources in medicine use (29), to promote safe, rational, and cost-effective 
use of medicines (28), and to support advanced medication (4).  
 
Many respondents were also aware of the importance of transparency in 
pharmaceutical procurement. WHO also published operational principles for 
good pharmaceutical procurement which outlined separation of 
responsibilities between offices, committees, or individuals; and regular 
monitoring to achieve efficient and transparent management (29). However, 
poor procurement practices were reported as still common (30).  
 
Some participants were aware of different capacity of each facility to perform 
pharmaceutical services. Although national standards provide guides for 
hospital pharmacy managers to operate their department, adjustments in 
work flows and service provisions are still required (30). Expectations for 
simplification of documentation and access to drug and therapeutic 
information through networks were also expressed by participants. This wish 
is not surprising because of the many benefits of information technology in 
many aspects of pharmaceutical services, such as reduction of medication 
errors (31), simplification of tasks and process (32), perpetual monitoring 
(33), and an increase in data accuracy (32). Some hospital pharmacists also 
reported their ideal pharmaceutical distribution strategy, and very often they 
referred to other countries as models.   
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All participants expressed their wishes for strong hospital leadership. 
Leadership is defined as the process of influence in which one person is able 
to enlist the aid and support of others in accomplishing a common task (34). 
In hospital, services are always complex because they are delivered by 
collaboration involving many technical and health professionals (35). Leaders 
were also expected to have particular competencies, such as long-range 
strategic thinking, people development, flexibility, and ability to change (36). 
Participants also described their expectations to be engaged in service 
provision and target management. They wished to have a transformational 
and democratic leader rather than a laissez-faire and autocratic one (34). 
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6. Conclusions 
 
 
6.1. Summary of main findings 
Previous research has highlighted beneficial relationships between pharmacy 
management and organisational structure with improvement of service 
provision, management of total costs of care, and reduction in mortality rates. 
However, current trends in the roles of hospital pharmacists have shifted 
towards clinical pharmacy practice, and many pharmacists tend to overlook, 
and undervalue the importance of management practice in hospital 
pharmacy.  
 
A systematic review of hospital pharmacy management at international level 
is presented in Chapter 1 of this thesis and the findings indicate good 
evidence of the benefit of effective management of hospital pharmacy. This is 
particularly in a dynamic healthcare environment, where it may be associated 
with cost-efficiency, improved medication safety, and supportive work 
environments. However, some aspects of pharmacy management, such as 
human resource management, have received more attention than the other 
aspects of management. Moreover, the majority of studies were conducted in 
developed countries, and relatively little is known about pharmacy 
management and its impact in developing countries.  
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To gain more understanding about current issues, and potential future 
application of hospital pharmacy management in developing countries, an 
inductive, qualitative study with semi-structured interviews were conducted 
and reported in Chapters 3 – 5. A preliminary study conducted in a 
developed country (Australia) was also deemed beneficial and was reported 
in Chapter 2.  
 
The first stage of this research explored Australian hospital pharmacists’ 
perceptions in hospital pharmacy management. Australia was chosen for its 
proximity to researchers’ location. The findings highlighted the importance of 
pharmacy management skills in this setting. However, ideas about how 
hospital pharmacy should be managed are still debated. There remains a 
tension between professional autonomy and multidisciplinary environments. 
Pharmacists may lack motivation to pursue and develop excellence in 
pharmacy management as a prioritised professional role. To foster 
accountable practice in management, leadership in pharmacy must be 
realised. Support from hospital executives, regulators, professional 
organisations, pharmacy educators, and other practitioners should be sought.  
 
The second stage of the research reported in this thesis explored Indonesian 
hospital pharmacists’ perceptions of their current roles, experiences and 
concerns in the management of hospital pharmacy, and future direction and 
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vision for hospital pharmacy practice. Firstly, the Indonesian hospital 
pharmacists reported that pharmaceutical care was essential for patient-
oriented care. However, multiple interpretations of 'patient-oriented' and 
'pharmaceutical care' were found among pharmacist participants. This was 
reflected in varying extent to which pharmacists accepted or 'refused' roles 
and responsibilities in clinical services, management and leadership. 
Secondly, the Indonesian hospital pharmacists reported that they worked in 
constant tensions between finite resources and increasing demands. 
However, current pharmacy management activities focused on operational 
issues, with a lack of strategic planning. Much room for improvement in 
health-system and leadership is clear. Finally, the Indonesian hospital 
pharmacists reported their desire for a greater professional recognition for 
their contribution to patient care and the healthcare sector overall. Changes 
in health system and strong leadership were highly desirable features 
reported by study participants.  
 
In summary, both Indonesian and Australian hospital pharmacists have 
different ideas of patient-centred care, with different approaches to its 
applications. Australian hospital pharmacists are more receptive to 
managerial responsibilities. This may be because in the Australian health 
system, public hospital pharmacy is not an income-generating unit (as 
opposed to the current Indonesian health system). To improve healthcare 
services, strategic allocation of resources is essential. In contrast, the 
majority of Indonesian hospital pharmacists reject managerial roles 
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(associated with inventory tasks). Those tasks are deemed bureaucratic, 
frustrating, lacking in professional autonomy, and as not having any 
contribution in improvement of healthcare. Hence, they expect the 
managerial roles to be taken over by systems (such as regulations or 
computerised systems). Much focus was given to manage daily operations, 
and little to plan strategically. Indonesian hospital pharmacists could benefit 
from their managerial opportunities in current national health system which 
focused much on resource efficiency. Furthermore, Australian hospital 
pharmacists tend to initiate changes. On the other hand, Indonesian hospital 
pharmacists wished for a top-down approach to initiate change. The culture 
of organisations may be the chief influencing factor of those attitudes. Hence, 
Indonesian hospital pharmacists may benefit from taking over leadership 
positions in healthcare facility. 
 
6.2. Implications for practice 
The research shows there is potential benefit in high quality hospital 
pharmacy management in improvement of health care. The findings of this 
research highlighted potential gaps in ideas about patient-centred care and 
management among practitioners. The gaps are likely to hinder hospital 
pharmacists’ contribution to welfare of their communities. Different 
perceptions of ideal hospital pharmacy practice and service provisions also 
suggested potential challenges for development.  
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In Indonesia, there appeared to be room for improvement, particularly in 
planning and leadership activities. Unsupportive hospital environments and 
lack of recognition suggested potential threats towards the future. Given the 
constant changes in national health system and regulations, with different 
capacities to provide resources throughout the vast country, hospital 
pharmacy may face significant challenges and/or develop different pharmacy 
services. In low-resource settings, such as in some hospitals in Indonesia, 
strategic planning may equip hospital pharmacy managers to improve service 
provision, allocation of resources, and work environment. Application of 
transformational leadership may foster supportive work environment and 
collaboration among health professionals. 
 
6.3. Limitations of the research 
As a qualitative study, the findings of the present study may not represent the 
perceptions of all hospital pharmacists in Australia or Indonesia. One 
important limitation of this study is the relatively small number of participants 
relative to whole population of pharmacists in hospital practice.  
 
In the first stage, participants were recruited from one metropolitan city in 
Australia. However, the aim of this stage was to provide an international 
perspective for the second stage. We have consulted key informants in the 
practice field, ranging from early-career pharmacists to Directors of 
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Pharmacy. Further work may include other areas of practice and 
geographical regions to gain deeper understanding about this topic. 
 
In the second stage, participants were recruited only from western regions in 
Indonesia. However, the necessity to gather diverse characteristics of 
participants is recognised, so data were sought from various types of 
pharmacists in multiple settings and provinces in Indonesia. Therefore, this 
research was able to capture widely-held perceptions and attitudes of 
hospital pharmacists which is likely to reflect the broader profession. 
Participants have contributed valuable information until saturation has been 
reached. During the data analysis process, emerging codes and themes 
were discussed with other researchers. 
 
6.4. Recommendations for future work 
The research described in this thesis highlighted underlying philosophies of 
care in hospital pharmacy and its implications on practice. There appears to 
be room for consumer engagement in this practice model. Potential 
applications of leadership and pharmacy management to improve medication 
safety, practice collaboration, and to develop pharmacy practice are also 
shown. 
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To prepare for this future, further research activity may focus on the following 
areas: 
1. Patient-centred care from the patients’ and other professions’ 
perspectives. It will be valuable to develop a strong basis for the 
pharmaceutical care philosophy. 
2. Hospital pharmacy autonomy and teamwork quality. Understanding of 
these may benefit educators, researchers, practitioners, hospital 
executives, and policy makers about defining pharmacists’ roles in 
hospital environment. 
3. Utilisation of strategic planning by hospital pharmacy managers, and 
factors specific for different type of hospitals that provide opportunities 
and challenge hospital pharmacy practice. This will facilitate strategy 
formulation to optimise hospital pharmacy contribution in responsible use 
of medicines and medical devices. 
4. Work satisfaction in hospital pharmacy and its related factors. Research 
on such topics may offer benefits for improvements in hospital pharmacy 
service. 
5. Drug and Therapeutics Committee (and other collaborative groups) 
contribution to hospital pharmacy management, and potential hospital 
pharmacists’ involvement. It may be valuable to explore different 
approaches to improving management of hospital medication use through 
interprofessional and collaborative processes. 
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6. Localised information systems, with consideration of institutional 
characteristics. Further research in this area could yield better 
understanding, and facilitate implementation of future electronic systems 
in hospitals. 
7. Effective leadership styles in the context of different hospitals or 
organisations. This may assist development of a strong basis in 
competencies building and professional leadership in hospital pharmacy. 
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PARTICIPANT INFORMATION STATEMENT 
 
(1) What is this study about? 
 
You are invited to take part in a research study about hospital pharmacy management. 
Past studies have shown that changes in national healthcare systems influenced the 
management of hospital pharmacy. Standards of Practice, and international and local 
guidelines have been utilised to assist managers to support delivery of health services.  
 
The purpose of the study is to explore the aspects of potential future issues in hospital 
pharmacy. The study also aims to identify the pressures, challenges, and opportunities in 
managing and optimizing resources in hospital pharmacy.  
 
You have been invited to participate in this study because you are identified as a senior 
hospital pharmacy manager/ key opinion leader/ potential future leader in hospital 
pharmacy. This Participant Information Statement tells you about the research study. 
Knowing what is involved will help you decide if you want to take part in the study. 
Please read this sheet carefully and ask questions about anything that you don’t 
understand or want to know more about.  
 
Participation in this research study is voluntary. So it’s up to you whether you wish to 
take part or not.  
 
By giving consent to take part in this study you are telling us that you: 
 Understand what you have read 
 Agree to take part in the research study as outlined below 
 Agree to the use of your personal information as described. 
 
You will be given a copy of this Participant Information Statement to keep. 
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(2) Who is running the study? 
 
The study is being carried out by the following researchers: 
 Professor Jo-anne Brien, Professor of Clinical Pharmacy, St. Vincent’s Hospital at the 
University of Sydney   
 Professor Andrew McLachlan, Professor of Pharmacy (Aged Care)  
 Vania Gones, Master of Philosophy candidate, Faculty of Pharmacy, University of 
Sydney. 
 
Vania Gones is conducting this study as the basis for the degree of Master of Philosophy 
(Pharmacy) at The University of Sydney. This will take place under the supervision of 
Professor Jo-anne Brien and Professor Andrew McLachlan. 
 
What will the study involve for me? 
 
 If you are willing to participate in this study, you will have a face-to-face interview with 
the researcher at the time and place that suits you. If you are unable to meet the 
researchers in person, you may prefer to have a phone interview at the time that suits 
you.  
 The interview will be recorded with an audio-recorder, but the recording can be stopped 
at any time if you do not wish to be recorded.  
 You will be asked questions related to: 
a. Your perceptions of and opinions about current and future challenges and 
important factors in managing hospital pharmacy. 
b. Your perceptions of and opinions about the current and future hospital pharmacy 
service provision. 
c. Your opinions about future changes in the healthcare system and its impact on 
hospital pharmacy management. 
d. Your perceptions of the healthcare systems in Australia. 
 
(3) How much of my time will the study take? 
 
The interview, either face-to-face or by phone will take approximately 30-60 minutes. 
 
(4) Do I have to be in the study? Can I withdraw from the study once I've started? 
 
Being in this study is completely voluntary and you do not have to take part. Your 
decision whether to participate will not affect your current or future relationship with 
the researchers or anyone else at the University of Sydney.  
 
If you decide to take part in the study and then change your mind later, you are free to 
withdraw at any time. You can do this by contacting Vania Gones at 
vania.gones@sydney.edu.au. 
 
You are free to stop the interview at any time. Unless you say that you want us to keep 
them, any recordings will be erased and the information you have provided will not be 
included in the study results. You may also refuse to answer any questions that you do 
not wish to answer during the interview. 
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(5) Are there any risks or costs associated with being in the study? 
 
Aside from giving up your time, we do not expect that there will be any risks or costs 
associated with taking part in this study. 
 
(6) Are there any benefits associated with being in the study? 
 
We cannot guarantee or promise that you will receive any direct benefits from being in 
the study. 
 
(7) What will happen to information about me that is collected during the study? 
 
Your interview will be recorded by an audio-recorder and it will be transcribed verbatim 
by a researcher. Your interviewer will also take notes during interview. The transcription 
will be analysed by researchers to identify the topics. The results will be used for journal 
publications, conference presentations, and for development of a nation-wide survey.  
 
By providing your consent, you are agreeing to us collecting personal information about 
you for the purposes of this research study. Your information will only be used for the 
purposes outlined in this Participant Information Statement, unless you consent 
otherwise. 
 
Your information will be stored securely and your identity/information will only be 
disclosed with your permission, except as required by law. Study findings may be 
published, but you will not be identified in these publications unless you agree to this 
using the tick box on the consent form. 
 
(8) Can I tell other people about the study? 
 
Yes, you are welcome to tell other hospital pharmacists about the study. 
 
(9) What if I would like further information about the study? 
 
When you have read this information, Vania Gones will be available to discuss it with 
you further and answer any questions you may have. If you would like to know more at 
any stage during the study, please feel free to contact Vania Gones, as a researcher at 
vania.gones@sydney.edu.au. 
 
(10) Will I be told the results of the study? 
 
You have a right to receive feedback about the overall results of this study. You can tell 
us that you wish to receive feedback by ticking the relevant box on the consent form. 
This feedback will be in the form of a one-page summary. You will receive this feedback 
after the study is finished.  
 
(11) What if I have a complaint or any concerns about the study? 
 
Research involving humans in Australia is reviewed by an independent group of people 
called a Human Research Ethics Committee (HREC). The ethical aspects of this study 
have been approved by the HREC of the University of Sydney with project number 
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2014/680. As part of this process, we have agreed to carry out the study according to 
the National Statement on Ethical Conduct in Human Research (2007). This statement 
has been developed to protect people who agree to take part in research studies. 
 
If you are concerned about the way this study is being conducted or you wish to make a 
complaint to someone independent from the study, please contact the university using 
the details outlined below. Please quote the study title and protocol number.  
 
The Manager, Ethics Administration, University of Sydney: 
 Telephone: +61 2 8627 8176 
 Email: ro.humanethics@sydney.edu.au 
 Fax: +61 2 8627 8177 (Facsimile) 
  
 
This information sheet is for you to keep 
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PARTICIPANT CONSENT FORM 
 
I, ................................................................................... [PRINT NAME], agree to take part in this 
research study. 
 
In giving my consent I state that: 
 
 I understand the purpose of the study, what I will be asked to do, and any risks/benefits 
involved.  
 
 I have read the Participant Information Statement and have been able to discuss my 
involvement in the study with the researchers if I wished to do so.  
 
 The researchers have answered any questions that I had about the study and I am happy with 
the answers. 
 
 I understand that being in this study is completely voluntary and I do not have to take part. My 
decision whether to be in the study will not affect my relationship with the researchers or 
anyone else at the University of Sydney now or in the future. 
 
 I understand that I can withdraw from the study at any time. 
 
 I understand that I may stop the interview at any time if I do not wish to continue, and that 
unless I indicate otherwise any recordings will then be erased and the information provided 
will not be included in the study. I also understand that I may refuse to answer any questions 
I don’t wish to answer. 
 
 I understand that personal information about me that is collected over the course of this 
project will be stored securely and will only be used for purposes that I have agreed to. I 
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understand that information about me will only be told to others with my permission, except 
as required by law. 
 
 I understand that the results of this study may be published, but these publications will not 
contain my name or any identifiable information about me unless I consent to being 
identified using the “Yes” checkbox below. 
 
 Yes, I am happy to be identified. 
 
 No, I don’t want to be identified. Please keep my identity anonymous. 
 
 
I consent to:  
 
 Audio-recording   YES  NO  
 
 Being contacted about future studies  YES  NO  
 
 
 
Would you like to receive feedback about the overall results of this study?  
     
    YES  NO  
If you answered YES, please indicate your preferred form of feedback and address: 
 
 Postal:  _______________________________________________________ 
 
___________________________________________________ 
 
 Email: ___________________________________________________ 
 
 
 
 
 
 
................................................................. 
Signature  
 
 
 
 .............. .................................................... 
PRINT name 
 
.................................................................................. 
Date 
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Interview Guide 
 
 
Questions for Hospital Pharmacy Managers 
1. How is your current hospital management like? 
a. What is a typical day of work for you? 
b. Whom do you report to? 
c. What is the culture of work in your hospital? 
d. What sort of issues that you have on a daily basis? 
2. How is the current pharmacy management like? 
a. What are the services and products that are provided and managed by your 
department? 
b. What kind of tools that you use in your department to run the services? What 
do you like about it? What do you dislike about it? How do you think it can be 
improved? 
c. As a manager, how do you develop local policy directives? 
d. What is the basis in developing the policy? 
e. What kind of financial support required in managing the department? 
f. How does budgeting take place in the department? 
g. How do you plan staffing requirements in your department? 
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h. What sort of opportunities do you provide about continuing education, 
career progression for your staff? 
i. What are current policies in handling medication safety? 
j. What are 3-4 perceived key elements to successfully manage hospital 
pharmacy? 
3. What are the perceived challenges in managing hospital pharmacy? 
a. What was the major change that took place in the past which challenged you 
to successfully manage the department? 
b. Are there any issues that you perceive in doing as challenges in managing 
your department? 
4. What is the potential future development of hospital pharmacy? 
a. What do you say as the future hospital pharmacy? 
b. What is your expectation of it? 
c. What is your future direction? 
d. How do you think it will affect your work? 
e. How do you think the pharmacy professional adapt to it?
 
The Future of Management of Hospital Pharmacy Services   
Version 2, November 20, 2014 
Questions for Interns/ Early career pharmacists 
1. What is your current work like? 
a. What is a typical day of work for you? 
b. Whom do you report to? 
c. What is the culture of work in your department? 
d. What sort of issues that you have on a daily basis? 
2. How is current pharmacy management like? 
a. What is local policy directive in your department like? How is the 
implementation of the policy? 
b. How does budgeting take place in your department? 
c. Do you think that your department has adequate staff? 
d. What opportunity is available in your department to career development? 
e. In providing pharmacy services, which are sometimes high-risk, how is the 
general procedure for handling the medication safety? Do you feel that 
sufficient? 
f. What is the medication management system that you use to do your day-to-
day work? What do you like about it? What do you dislike about it? What is 
your expectation from it? How do you think it can be improved? 
g. What are 3-4 key elements to successfully perform your work? 
3. What are the perceived challenges in working in hospital pharmacy? 
a. Was there any changes in the past in your department that challenged your 
day-to-day work? 
b. Are there any other issues that you perceived as challenges as working as a 
pharmacist in the hospital? 
4. What do you think the future of hospital pharmacy will be? 
a. What is your future direction? 
b. What do you think will change or needs to be changed? 
c. How do you think it will affect your day-to-day practice? 
d. How do you think you will adapt to it? 
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The Future of Management of Hospital Pharmacy Services 
(Masa Depan Manajemen Farmasi Rumah Sakit ) 
LEMBAR PENJELASAN 
(1) Apa maksud dari penelitian ini? 
 
Anda diundang untuk berpartisipasi dalam penelitian tentang pengelolaan farmasi rumah 
sakit. Penelitian-penelitian sebelumnya telah menunjukkan bahwa perubahan dari sistem 
kesehatan nasional berpengaruh terhadap pengelolaan farmasi rumah sakit. Standar dan 
pedoman praktik kefarmasian internasional dan nasional telah disusun sebagai acuan para 
apoteker dalam memberikan layanan kefarmasian di rumah sakit. 
 
Tujuan dari penelitian ini adalah untuk mengeksplorasi potensi perkembangan farmasi 
rumah sakit di masa depan. Penelitian ini juga bertujuan untuk mengidentifikasi hambatan, 
tantangan, dan kesempatan dalam mengelola dan mengoptimalisasi sumber daya yang 
tersedia di farmasi rumah sakit. 
 
Anda diundang sebagai peserta dalam penelitian ini karena Anda merupakan kepala instalasi 
farmasi rumah sakit/ pemuka dalam farmasi rumah sakit/ calon pemimpin instalasi farmasi 
rumah sakit. Pernyataan Informasi Peserta ini memberikan gambaran mengenai penelitian 
yang akan dilakukan. Mohon Anda membaca dokumen ini dan bertanya apabila ada hal-hal 
yang kurang dipahami atau hendak diketahui lebih lanjut. 
 
Berpartisipasi dalam penelitian ini bersifat sukarela dan tanpa paksaan. Keputusan untuk 
berpartisipasi/tidak dalam penelitian ini sepenuhnya merupakan keputusan Anda.  
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Dengan memberikan persetujuan berpartisipasi, Anda menyatakan bahwa Anda telah: 
 Memahami informasi yang telah disampaikan 
 Menyetujui untuk berpartisipasi dalam penelitian yang dimaksud oleh pernyataan ini 
 Menyetujui untuk memberikan informasi pribadi sebagaimana dijelaskan di dalam 
pernyataan ini 
Anda akan diberikan salinan Lembar Penjelasan ini sebagai pegangan. 
 
(2) Siapa yang menjalankan penelitian ini? 
 
Penelitian ini dilakukan oleh: 
 Professor Jo-anne Brien, Professor Farmasi Klinik, St. Vincent’s Hospital, University of Sydney 
 Professor Andrew McLachlan, Professor Farmasi, University of Sydney 
 Retnosari Andrajati, Pengajar, Departemen Farmakologi dan Farmasi Klinik, Fakultas Farmasi 
Universitas Indonesia 
 Vania Gones, kandidat Master of Philosophy, Faculty of Pharmacy University of Sydney 
Vania Gones melakukan penelitian ini sebagai syarat pendidikan Master of Philosophy 
(Pharmacy) di University of Sydney. Penelitian ini dilakukan di bawah bimbingan Professor  
Jo-anne Brien, Professor Andrew McLachlan, dan Retnosari Andrajati. 
Sejauh apa keterlibatan saya dalam penelitian ini? 
 
 Jika Anda bersedia untuk berpartisipasi dalam penelitian ini, Anda akan diwawancara oleh 
peneliti pada waktu dan tempat yang telah disepakati. Jika Anda tidak dapat bertemu oleh 
peneliti secara langsung, Anda boleh memilih untuk melakukan wawancara melalui telepon. 
 Wawancara akan direkam dengan perekam suara, tetapi rekaman dapat dihentikan sewaktu-
waktu jika Anda menolak untuk diwawancara. 
 Anda akan diwawancara mengenai: 
a. Pandangan dan pendapat Anda mengenai hambatan dan tantangan, serta faktor-faktor 
yang berpengaruh dalam mengelola farmasi rumah sakit. 
b. Pandangan dan pendapat Anda mengenai ketentuan dan pengelolaan pelayanan farmasi 
di rumah sakit saat ini dan di masa depan. 
c. Pendapat Anda mengenai perubahan sistem kesehatan di masa depan dan dampaknya 
terhadap manajemen farmasi rumah sakit. 
d. Pandangan Anda mengenai sistem pelayanan kesehatan, khususnya pelayanan farmasi 
di Indonesia. 
 
(3) Berapa lama waktu yang akan saya sediakan untuk penelitian ini? 
 
Wawancara tersebut, baik tatap muka maupun melalui telepon, akan dilakukan selama 30-60 
menit. 
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(4) Apakah saya boleh menarik diri dari penelitian setelah berpartisipasi? 
 
Berpartisipasi dalam penelitian ini bersifat sukarela dan tanpa paksaan. Keputusan Anda 
untuk berpartisipasi atau tidak berpartisipasi tidak akan mempengaruhi hubungan Anda 
dengan peneliti maupun dengan pihak lain di University of Sydney. 
 
Jika Anda bersedia untuk berpartisipasi, namun ingin menarik diri dari penelitian ini, Anda 
dapat memutuskan untuk berhenti kapan pun dengan menghubungi Vania Gones di 
vania.gones@sydney.edu.au. 
 
Anda juga berhak untuk menghentikan wawancara kapan pun. Semua bentuk rekaman dan 
informasi yang telah diberikan tidak akan disajikan dalam hasil penelitian, kecuali Anda 
menyatakan lain. Anda juga dapat menolak untuk menjawab pertanyaan yang kurang 
berkenan selama wawancara berlangsung. 
 
(5) Apakah saya akan mengeluarkan biaya atau mendapat resiko dengan berpartisipasi? 
 
Selain dari waktu yang diperlukan selama wawancara, tidak ada resiko atau biaya untuk 
berpartisipasi dalam penelitian ini. 
 
(6) Apakah keuntungan dengan menjadi peserta? 
 
Kami tidak dapat menjamin atau menjanjikan Anda akan menerima keuntungan langsung 
berpartisipasi dalam penelitian ini. 
 
(7) Apa yang akan dilakukan kepada informasi yang telah saya berikan selama penelitian? 
 
Percakapan Anda selama wawancara akan direkam oleh perekam suara dan akan disalin 
secara harafiah oleh peneliti. Pewawancara juga akan mengambil catatan selama wawancara 
berlangsung. Salinan wawancara kemudian akan dianalisa oleh peneliti untuk mencari topik-
topik yang termaktub. Hasil penelitian akan digunakan sebagai bahan publikasi ilmiah melalui 
jurnal, presentasi seminar, dan untuk pengembangan survey nasional.  
 
Ketika Anda menyetujui untuk berpartisipasi, maka Anda menyatakan telah bersedia untuk 
memberikan informasi pribadi untuk tujuan penelitian ini. Data pribadi Anda hanya akan 
digunakan untuk tujuan yang telah disampaikan di dalam Lembar Penjelasan ini, kecuali Anda 
menyatakan lain. 
 
Data pribadi Anda akan disimpan dengan aman, dan akses kepada data/identitas Anda hanya 
akan diberikan melalui persetujuan Anda, terkecuali jika dipersyaratkan oleh hukum. Hasil 
penelitian akan dipublikasikan, tetapi identitas Anda akan bersifat anonim, kecuali jika Anda 
menyatakan lain (dan telah mencentang kotak terkait di Lembar Persetujuan). 
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(8) Dapatkah saya menyebarkan informasi mengenai penelitian ini? 
 
Ya, Anda dapat menyebarkan informasi mengenai penelitian ini kepada apoteker lain yang 
bekerja di rumah sakit. 
 
(9) Apa yang harus saya lakukan jika saya memerlukan informasi tambahan terkait penelitian 
ini? 
 
Jika Anda ingin berdiskusi lebih lanjut mengenai penelitian ini, silahkan menghubungi Vania 
Gones (peneliti) melalui vania.gones@sydney.edu.au atau 0821 2298 6469.  
 
(10) Apakah saya akan diinformasikan hasil penelitian ini? 
 
Anda berhak untuk memperoleh hasil penelitian secara keseluruhan. Jika Anda ingin 
mendapatkan hasil penelitian, silahkan mencentang kotak terkait di Lembar Persetujuan. 
Hasil penelitian yang diberikan berupa rangkuman dan akan diberikan setelah penelitian 
berakhir. 
 
(11) Bagaimana jika saya memiliki keluhan atau perhatian khusus tentang penelitian ini? 
 
Penelitian ini telah disetujui oleh Komite Etik di University of Sydney dengan nomor 
2014/680. Lembar pernyataan ini telah disusun untuk melindungi peserta penelitian ini. 
 
Apabila Anda memiliki saran atau keluhan atas penelitian ini, silahkan menyampaikan 
saran/keluhan Anda ke Ikatan Apoteker Indonesia di: 
 Email: sekretariat@ikatanapotekerindonesia.net 
 Telepon: 021 567 1800 atau 021 5696 2581 
Maupun ke universitas melalui kontak yang tercantum di bawah ini. Harap cantumkan judul 
dan nomor penelitian. 
Manager, Ethics Administration, University of Sydney: 
 Telepon: +61 2 8627 8176 
 Email: ro.humanethics@sydney.edu.au 
 Fax: +61 2 8627 8177 
 
Lembar Penjelasan ini untuk disimpan oleh Anda 
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(Masa Depan Manajemen Farmasi Rumah Sakit ) 
LEMBAR PERSETUJUAN 
Saya, ……………………………………………………….. [CANTUMKAN NAMA], setuju untuk menjadi responden 
dalam penelitian ini. 
Dengan menandatangani formulir ini, saya menyatakan bahwa: 
 Saya telah memahami tujuan dari penelitian ini, apa yang diharapkan dari saya, serta resiko 
dan keuntungan yang akan saya terima. 
 
 Saya telah membaca Pernyataan Informasi Peserta dan telah berdiskusi tentang partisipasi 
saya dalam penelitian ini dengan peneliti. 
 
 Peneliti telah menjawab pertanyaan-pertanyaan yang saya ajukan dan jawaban telah dapat 
saya terima dengan baik. 
 
 Saya paham bahwa berpartisipasi dalam penelitian ini bersifat sukarela dan tanpa paksaan. 
Keputusan saya untuk berpartisipasi tidak akan mempengaruhi hubungan saya dengan 
peneliti atau dengan siapa pun di University of Sydney. 
 
 Saya paham bahwa saya dapat menarik diri dari penelitian ini kapan pun. 
 
 Saya paham bahwa saya dapat menghentikan wawancara kapan pun, dan kecuali saya 
menyatakan lain, maka seluruh rekaman akan dihapus dan informasi yang telah saya berikan 
tidak akan disajikan di dalam hasil penelitian. Saya juga paham bahwa saya berhak menolak 
pertanyaan yang kurang berkenan. 
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 Jo-anne Brien 
BPharm BS (Pharm), PharmD, FRPharmS 
Professor of Clinical Pharmacy (St Vincent's Hospital) 
 
Room S343 
A15 – Pharmacy and Bank Building 
The University of Sydney  
NSW 2006 AUSTRALIA 
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Email: jo-anne.brien@sydney.edu.au 
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 Saya paham bahwa data pribadi saya akan disimpan dengan aman dan hanya akan digunakan 
sesuai persetujuan saya. Saya paham bahwa data pribadi saya tidak akan disampaikan 
kepada pihak mana pun, kecuali ketika dipersyaratkan oleh hukum. 
 
 Saya paham bahwa hasil penelitian ini dapat dipublikasikan, tetapi identitas saya akan 
bersifat rahasia, kecuali saya menyatakan bersedia mencantumkan identitas pribadi saya di 
dalam publikasi dengan mencentang kotak “Ya” di bawah ini. 
 Ya, saya bersedia agar identitas saya dicantumkan. 
 
 Tidak, saya tidak bersedia identitas saya dicantumkan. Mohon tetap menjaga 
kerahasiaan identitas pribadi saya. 
 
Saya telah menyetujui untuk: 
 
• Direkam dengan perekam suara  YA  TIDAK  
 
• Dihubungi kembali untuk penelitian berikutnya  YA  TIDAK  
 
Apakah Anda ingin memperoleh hasil keseluruhan penelitian ini?  
     
    YA  TIDAK  
Jika Anda menjawab YA, silahkan memilih bentuk penyampaian hasil penelitian dan 
alamat yang dimaksud: 
 
 Alamat pos:  _______________________________________________________ 
 
 ___________________________________________________ 
 
 Alamat email: ___________________________________________________ 
 
 
 
 
 
 
................................................................. 
Tanda Tangan  
 
 
 
 .............. .................................................... 
[NAMA LENGKAP] 
 
.................................................................................. 
Tanggal 
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Questions for Hospital Pharmacy Managers 
1. How is your current hospital management like? 
a. What is a typical day of work for you? 
b. Whom do you report to? 
c. What is the culture of work in your hospital? 
d. What sort of issues that you have on a daily basis? 
2. How is the current pharmacy management like? 
a. What are the services and products that are provided and managed by your 
department? 
b. What kind of tools that you use in your department to run the services? What 
do you like about it? What do you dislike about it? How do you think it can be 
improved? 
c. As a manager, how do you develop local policy directives? 
d. What is the basis in developing the policy? 
e. What kind of financial support required in managing the department? 
f. How does budgeting take place in the department? 
g. How do you plan staffing requirements in your department? 
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h. What sort of opportunities do you provide about continuing education, 
career progression for your staff? 
i. What are current policies in handling medication safety? 
j. What are 3-4 perceived key elements to successfully manage hospital 
pharmacy? 
3. What are the perceived challenges in managing hospital pharmacy? 
a. What was the major change that took place in the past which challenged you 
to successfully manage the department? 
b. Are there any issues that you perceive in doing as challenges in managing 
your department? 
4. What is the potential future development of hospital pharmacy? 
a. What do you say as the future hospital pharmacy? 
b. What is your expectation of it? 
c. What is your future direction? 
d. How do you think it will affect your work? 
e. How do you think the pharmacy professional adapt to it?
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Questions for Interns/ Early career pharmacists 
1. What is your current work like? 
a. What is a typical day of work for you? 
b. Whom do you report to? 
c. What is the culture of work in your department? 
d. What sort of issues that you have on a daily basis? 
2. How is current pharmacy management like? 
a. What is local policy directive in your department like? How is the 
implementation of the policy? 
b. How does budgeting take place in your department? 
c. Do you think that your department has adequate staff? 
d. What opportunity is available in your department to career development? 
e. In providing pharmacy services, which are sometimes high-risk, how is the 
general procedure for handling the medication safety? Do you feel that 
sufficient? 
f. What is the medication management system that you use to do your day-to-
day work? What do you like about it? What do you dislike about it? What is 
your expectation from it? How do you think it can be improved? 
g. What are 3-4 key elements to successfully perform your work? 
3. What are the perceived challenges in working in hospital pharmacy? 
a. Was there any changes in the past in your department that challenged your 
day-to-day work? 
b. Are there any other issues that you perceived as challenges as working as a 
pharmacist in the hospital? 
4. What do you think the future of hospital pharmacy will be? 
a. What is your future direction? 
b. What do you think will change or needs to be changed? 
c. How do you think it will affect your day-to-day practice? 
d. How do you think you will adapt to it? 
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Questions for members of the Indonesian government and professional association 
1. What do you think about current hospital pharmacy practice? 
a. What are hospital pharmacists’ roles and functions in your opinion? 
b. What do you think as key factors in management of hospital pharmacy? 
c. What are common issues in management of hospital pharmacy? 
2. How do you think about current health system and regulations? 
a. What do you think about current standard of hospital pharmacy practice? 
b. What is the basis in the development of the standard? 
c. What are the indicators to assess hospital pharmacy performance? 
d. With current changes in the national health system, what changes are 
significant to hospital pharmacy? 
3. What is your expectations for the future? 
a. What is your future direction? 
b. What do you think will change or needs to be changed? 
c. How do you think it will affect hospital pharmacists’ day-to-day practice? 
d. How do you think they will adapt to it? 
 
